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ABSTRACT 
A COMPARATIVE STUDY OF EPIDURAL BUTORPHANOL AND 
EPIDURAL FENTANYL  AS  ADJUVANTS TO BUPIVACAINE IN LOWER 
ABDOMINAL SURGERIES: 
Background:  
Epidural opioids acting through the spinal cord receptors improve the quality and 
duration of analgesia along with dose-sparing effect with the local anesthetics. The 
present study compared the efficacy and safety profile of epidurally administered 
butorphanol and fentanyl combined with bupivacaine (B).  
Materials and Methods:  
A total of 60 adult patients of either sex of American Society of Anesthesiologist 
physical status I and II, aged 20-60 years, undergoing lower abdominal surgeries 
under epidural anesthesia were enrolled into the study. Patients were randomly 
divided into two groups of 30 each:  bupivacaine + butorphanol (BB) and 
bupivacaine + fentanyl (BF). Total volume of 20ml of 0.5% bupivacaine was 
administered epidurally in both the groups with the addition of 1 mg butorphanol 
in BB group and 100 µg fentanyl in the BF group. The hemodynamic parameters 
as well as various block characteristics including onset, completion, level and 
duration of sensory analgesia,quality of analgesia as well as onset and completion 
of motor block were observed and compared. Adverse events and post-operative 
visual analgesia scale scores were also noted and compared. Data was analyzed 
using Chi-square test and Fisher’s exact test. Value of P < 0.05 was considered 
significant and P < 0.001 as highly significant.  
Results:  
The demographic profile of patients was comparable in both the  groups. Onset and 
completion of sensory analgesia was earliest in BB group, followed by BF group 
but was not statistically significant. The duration of analgesia was significantly 
prolonged in BB group followed by BF  which was statistically significant. 
Addition of butorphanol and fentanyl to Bupivacaine had no effect on the time of 
onset and completion of motor block. No serious cardio-respiratory side effects 
were observed in any group.  
Conclusions:  
Butorphanol and fentanyl as epidural adjuvants are equally safe and provide 
comparable stable hemodynamics, early onset and establishment of sensory 
anesthesia. Butorphanol provides a significantly prolonged post-operative 
analgesia. 
Key words: Bupivacaine, butorphanol, epidural anesthesia, fentanyl, lower 
abdominal surgeries. 
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INTRODUCTION 
 
 The international association for the study of pain defines pain as 
“an unpleasant actual or potential tissue damage or described in terms of 
such damage.So pain is not just a sensory modality but it is an 
experience.There is an interplay between objective, physiological,sensory 
components of pain and its subjective,emotional, psychological 
components. Other than pshychological trauma, pain is shown to affect the 
physiology of almost all the systems including respiratory, cardiovascular 
and metabolic profile thereby increasing morbidity1. 
 Therefore proper management of pain remains one of the most 
important domain in particular to health care professionals.Modern day 
anaesthetic techniques are not only confined in relieving pain during 
surgery but also during postoperative period. 
 Anaesthetic techniques can be categorized into local, conscious 
sedation, regional and general anaesthesia.. The type of anaesthesia a 
patient receives depends on the procedure being performed, 
physical/emotional status as well as medical and psychological health. It is 
possible to perform all surgeries under general anaesthesia, but addition of 
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regional techniques to the anaesthesiologist’s armamentarium adds 
flexibility and skills that benefits the patients intra and post-operatively. 
Epidural anaesthesia/analgesia is one of the best accepted and most  
commonly employed technique in modern anaesthesiology for lower 
abdominal, pelvic, perineal, thoracic and lower limb surgeries.It provides 
surgical anaesthesia as well as postoperative analgesia.Any peripheral 
tissue injury including surgery leads to long term alterations in pain 
pathway leading to reduction in pain threshold and amplification of pain 
response2. 
Postoperative  pain treatment should be an integral part of routine 
surgical and anaesthetic management both for humanitarian reasons and to 
reduce morbidity, associated complications as well as to accelerate 
rehabilitation. Good perioperative analgesia is an important avenue to 
attenuate surgical stress response3.  
Epidural anaesthesia provides  good operative conditions with good 
sensory and motor blockade, contracted bowels retaining adequate 
spontaneous respiration, hemodynamic stability and facilities for 
postoperative analgesia. Discovery of  opioid receptors in the spinal cord 
and subsequent development of epidural/intrathecal administration of 
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opioid has opened a new horizon in pain management in the perioperative 
period. 
Bupivacaine is widely used in epidural anaesthesia. It is an amide 
local anaesthetic with asymmetric carbon atom.This drug is widely used 
for epidural anaesthesia and analgesia because of its long duration of 
action and differential blockade in lower concentrations. 
      Fentanyl is an phenyl piperidine derivative and synthetic opioid 
agonist with rapid onset and short duration of action. It  is 75 – 125 times 
more potent than morphine. 
     Butorphanol tartarate is a synthetic opioid agonist and anagonist 
with analgesic potency 4-8 times that of morphine. It is considered safe 
than pure opioid  agonist because of its ceiling effect on respiratory 
depression,lower addiction potential with sedation comparable to or more 
than morphine, lesser incidence of  nausea,vomiting,pruritis which is 
desirable in the post operative period3. 
 The present study  was designed to compare epidural bupivacaine 
with butorphanol and epidural  bupivacaine with fentanyl in lower 
abdominal surgeries. 
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AIMS AND OBJECTIVES OF THE STUDY 
This study  aims to compare the efficacy of  butorphanol and fentanyl 
added as adjuvants to bupivacaine in epidural anaesthesia for elective 
lower abdominal surgeries. The following points would be considered for 
comparison: 
1.Onset and completion of sensory blockade 
2.Level of sensory block  
3.Quality of analgesia 
4.Duration of analgesia 
5.Sedation scores 
6.Side effects 
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EPIDURAL ANAESTHESIA 
HISTORY OF EPIDURAL ANAESTHESIA4,5: 
 Jean Enthuse Sicard and Ferdinand  in 1901 were the first to 
approach epidural space by caudal route with cocaine. Fidel Pages, a 
Spanish military surgeon in 1921 described his work with lumbar epidural 
anaesthesia and is considered as the father of modern epidural anaesthesia. 
In 1931, Archile Dogliotti, an Italian surgeon popularized segmental 
epidural anaesthesia and described the loss of  resistance technique. In 
1949, Martinez Curbelo, an Cuban anaesthesiologist practiced continous 
epidural anaesthesia using Tuohy-Huber needle and silk ureteral catheter. 
 
ANATOMY OF EPIDURAL SPACE6 
 A good understanding of spinal column, spinal canal and spinal 
ligaments through which the epidural needle passes is required for the 
success of epidural anaesthesia.It is by practice and experience that the 
anaesthesiologist will able to appreciate the resistance offered by the 
ligaments as the epidural needle advances through the epidural space. 
Epidural space can be defined as the area outside the dural sac but 
inside the spinal canal, extending from the foramen magnum to the 
sacrococcygeal ligament.  
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Epidural space is discontinous and is divided into posterior, lateral and 
anterior compartments. The posterior epidural space is of greatest 
relevance to the anaesthesiologist because this is where the epidural needle 
is placed in epidural anaesthesia/analgesia. 
BOUNDARIES OF THE EPIDURAL SPACE: 
The epidural space is bounded 
1.Cranially by the foramen of magnum 
2.Caudally by the saccrococcygeal ligament covering the sacral hiatus 
3.Anteriorly by the posterior longitudinal ligament 
4.Laterally by the vertebral pedicle 
5.Posteriorly by the ligamentum flavum and vertebral lamina  
Epidural space is most shallow anteriorly and deepest 
posteriorly.The antero-posterior dimension of the posterior epidural space 
is largest at mid lumbar levels,decreases at thoracic levels and disappears 
above C7. 
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CONTENTS OF THE EPIDURAL SPACE: 
The contents of the epidural space are: 
1.Loose areolar tissue 
2.Epidural fat: Most widespread material is fat predominantly located in 
the lateral and posterior epidural space with clinical importance in 
pharmacokinetics of epidurally administered drugs. 
3.31 pairs of spinal nerves with their dural cuff on their way to the 
intervertebral foramen. 
4.Sacral and coccygeal nerves 
5. Spinal arteries arising from different sources at different levels  enter the 
epidural space through the intervertebral foramen and supply the spinal 
cord,meninges, periosteum and ligaments. 
6. Vertebral venous plexus: A network of veins, the Batson venous plexus 
courses through the anterior and lateral parts of epidural space.These 
venous plexus communicates above with the intracranial venous sinuses, 
below with pelvic, portal and caval systems and also with intervertebral 
veins.  
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FIG 1: EPIDURAL SPACE- BOUNDARIES 
 
 
 
 
FIG 2A: EPIDURAL SPACE- CROSS SECTIONAL ANATOMY 
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FIG 2B: EPIDURAL SPACE- CS SHOWING THE ORIENTATION OF 
EPIDURAL NEEDLE IN VARIOUS PLANES 
 
Ligamentum flavum is an important landmark while identifying 
epidural space using epidural needle because penetrating this tissue 
produces a noticeable loss of resistance to air or liquid. This point of 
resistance should be identified because any further advancement results in 
inadvertant dural puncture. The ligamentum flavum will be perceived as a 
thicker ligament if the needle is kept in the midline . It is to maintain the 
midline position of the epidural needle (needle A) during lumbar epidural 
techniques. If an oblique approach is taken, a “false release” can be 
produced (needle C) or the perception of a thin ligament can be reinforced 
(needle B)7.  
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EPIDURAL SPACE AND NEGATIVE PRESSURE: 
In 1828 Heldt and Maloney described about negative extra dural  
pressure.Several factors contribute to the generation of subatmospheric 
pressure in the epidural space.The natural effect of Starling forces across 
the capillary walls produce a low fluid pressure in the tissues on the basis 
of oncotic pressure.This results in subatmospheric pressure and tissue 
collapse in the spaces of opposing surfaces of spinal canal, including the 
planes where dura opposes the epidural fat or canal wall, and between 
epidural fat and canal wall. 
 
The pressure in the epidural space is important for several reasons. 
First, the hanging drop method used to identify entry into the epidural 
space directly relies on recognition of subatmospheric pressure in the 
spinal canal.Secondly recent reports indicate that presence of epidural 
wave forms will reliably confirm needle placement in the epidural 
space.Lastly increase in epidural pressure above its natural subatmospheric 
pressure by infusion of solutions may cause adverse effects by displacing 
the CSF and raising ICT. 
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MECHANISM  OF ACTION OF LOCAL ANAESTHETICS IN 
EPIDURAL SPACE7: 
The principle site of action of local anaesthetics is that portion of 
nerve roots in the epidural space as the nerves emerge from the dura and 
then pass into intervertebral foramen. Also substantial amount of drug 
diffuse into the subarachanoid space for its action. But the final destination 
of epidurally administered drug is that they must be absorbed into the 
blood stream, which occurs  rapidly from the epidural space. 
The proposed site of action of  local anaesthetics in the epidural sapce: 
 
1. The ink cuff zone- spinal nerve roots with their dural sleeves 
2. Mixed spinal nerves at the intervertebral foramen 
3. Dorsal root ganglia 
4. Substance of the spinal cord 
The major routes of elimination of  local anaethetics from epidural space is 
uptake by: 
1.Blood vessels 
2.Extra dural fat 
3.Nerve tissue 
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PHYSIOLOGICAL EFFECTS OF EPIDURAL BLOCKADE 2,7,8: 
1.CARDIOVASCULAR EFFECTS: 
 Epidural anaesthesia/analgesia has primarily indirect effects on 
cardiovascular system.Drugs absorbed into systemic circulation from the 
epidural space may have direct effects on organ systems. The indirect 
effects are mediated primarily through blockade of sympathetic nervous 
system and include reflex response to the primary cardiovascular  effect. 
The extent of effect of neuraxial blockade on CVS depends on the number 
of spinal segments blocked. Most notable effect is systemic hypotension. 
Blockade below T4 results in dilatation of arteries and venous capacitance 
vessels, leading to decreased SVR and decreased venous return. The 
barorecptors are activated to produce vasoconstriction of the upper 
extremities. Blockade above T4 interrupts cardiac sympathetic fibres 
leading to bradycardia, decreased cardiac output and profound systemic 
hypotension. 
2.PULMONARY EFFECTS: 
 Epidural anaesthesia /analgesia has minor effects on respiratory 
physiology and these changes have minimal consequences in other wise 
healthy persons. During high thoracic epidural anaesthesia vital capacity 
decreases by 6%, total lung capacity decreases by 3.5% and the absolute 
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value of FEV1 decreases by 5%, FEV1/FVC ratio and tidal volume remain 
unchanged.Dense epidural anaesthesia does not affect at-rest respiratory 
function, but the ability to cough and clear secretions may be adversely 
affected.  
Gas exchange and ventilation-perfusion matching remained 
unchanged in elderly patients after lumbar epidural anaesthesia.Neither 
lumbar nor thoracic epidural anaesthesia impair the ventilatory response to 
hypercarbia or hypoxia in elderly patients. 
3.NEUROENDOCRINE EFFECTS: 
 Neuraxial blockade may influence nuroendocrine functions. 
Neuraxial blockade higher than T9-10 is associated with decreased  plasma 
epinephrine and norepinephrine levels.Neuraxial blockade may contribute 
to a mitigated stress response by direct blockade of both afferent and 
efferent signals. Epidural anaesthesia results in an increased tissue 
oxygenation compared to GA.  
Neuraxial  blockade ,although attenuated, does not inhibit the 
increases in  intra operative stress hormones like glucose,cortisol, 
catecholamines and ACTH. 
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4.VISCERAL EFFECTS: 
a. Bladder: Bladder is innervated by nerves travelling with  S2 through S4 
nerve roots. Sympathetic nerves to bladder originate at the low thoracic 
/high lumbar levels and parasympathetic innervation originates at the 
sacral levels.  Blockade of these nerve roots directly affect detrusor muscle 
and urinary sphincter function resulting in urinary retenion. 
b.Intestines: The sympathetic supply to abdominal viscera originates from 
T6 to T12-L1, while the parasympathetic supply to the gut is via the vagus 
nerve.  
Therefore,neuraxial blockade at the mid- low thoracic levels result 
in  sympathetic denervation and parasympathetic dominance, resulting in 
contracted gut,relaxed sphincters and normal peristalsis. 
5.THERMOREGULATION: 
Thermoregulation is impaired in neuraxial blockade,the predominant 
cause being decreased core temperature resulting from redistributiion of  
heat from core to periphery due to peripheral vasodilation.In addition, 
central thermo-regulatory response is also impaired. Sympathetic amd 
motor blockade preclude  vasoconstriction and shivering in the lower part 
of the body, but even in the upper half of the body, neuraxial blockade 
lower thermoregulatory vasoconstriction and shivering thresholds. 
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6.CENTRAL NERVOUS  SYSTEM: 
Cerebral blood flow is auto regulated;thus blood flow to central 
nervous system remains constant during neuraxial anaesthesia unless there 
is profound hypotension i.e., MAP <55mmHg in a normotensive 
individual.Sedation scores were directly related to the extent of segmental 
blockade .Sedation in neuraxial anaesthesia is due to decreased afferent 
input to the RAS.Neuraxial anaesthesia may be associated with a decreased 
incidence of  early postoperative cognitive dysfunction. 
 
7.DIFFERENTIAL BLOCKADE: 
The ability to block sensory,motor and sympathetic nerve functions 
to varying degree is called  ‘differential blockade’. Although smaller and 
myelinated fibres are generally said to be blocked more easily than larger 
and unmyelinated ones, the phenomenon of differential blockade appears 
to be more complex, especially for neuraxial anaesthesia. Sympathetic 
impulses carried by smaller C fibres are blocked earlier than larger sensory 
and motor fibres.As a result, level of sympathetic blockade is 2 to 6 
segments above the level of sensory blockade,which inturn is two 
segments higher than motor blockade. 
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INDICATIONS FOR EPIDURAL ANAESTHESIA: 
Epidural anaesthesia can be used for a variety of surgeries extending from 
neck to foot. 
 
COMMON APPLICATIONS OF EPIDURAL ANAESTHESIA: 
The common applications of epidural anaesthesia are: 
1.Prolonged orthopedic surgeries like major hip/knee surgeries, repair of 
pelvis   fractures 
2.Obstetrics and gynaecological surgeries like C-section, labour analgesia 
3.Urological surgeries involving prostrate, bladder and ureters 
4.Epidural  analgesia for upper abdominal and thoracic surgeries 
5.Epidural anaesthesia for lower abdominal and lower limb surgeries 
6.In high risk patients with respiratory problems 
7.Paediatric caudal for lower abdominal and lower limb surgeries. 
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CONTRAINDICATIONS FOR EPIDURAL ANAESTHESIA: 
ABSOLUTE:       
1.Patient refusal 
2.Infection at the site of planned needle puncture 
3.Elevated intracranial tension 
4.Bleeding diasthesis 
RELATIVE: 
1.Sepsis 
2.Uncooperative patient 
3.Preexisting neurological deficits 
4.Stenotic valvular lesions 
5.Severe spinal deformity   
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PREPARATION  FOR NEURAXIAL ANAESTHESIA 9,10: 
1.EMERGENCY DRUGS AND SUPPLIES: Adverse events are 
fortunately relatively infrequent,however immediate action must be taken 
when they occur in order to mitigate or prevent severe complications. The 
area where the block is to be performed must be equipped with an oxygen 
source,a means to administer postive pressure ventilation, equipment for 
airway management as well as emergency drugs. 
2.PATIENT PREPARATION: Patient preparation procedures that apply 
to general anaesthesia apply to neuraxial anaesthesia as well. A thorough 
preoperative evaluation should be performed, patient’s starvation status 
should be greater than 6hours for solids, and greater than 2hours for clear 
liquids.Informed written consent should be obtained and finally a back up 
plan in the event of failed neuraxial anaesthesia should be discussed. 
3.MONITORING:During the performance of neuraxial anaesthesia 
monitoring should include recording the baseline level of consciousness, 
continuous pulse oximetry and heart rate monitoring, non-invasive blood 
pressure monitoring and continuous ECG monitoring. Intraoperative 
monitoring should include ASA’s standard monitoring including 
temperature monitoring. 
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4.SEDATION:Light sedation may be administered before initiation of 
neuraxial anaesthesia, if this is desired by the patient and deemed 
appropriate by the anaesthesiologist. If spinal or epidural block is 
performed in the  preoperative  holding area and neuraxial drugs have been 
injected or sedation has been administered the patient should not be left 
alone or unmonitored. 
5.PATIENT POSITIONING: Careful attention to patient positioning is 
critical to successful epidural blockade.Epidural anaesthesia can be 
performed in the sitting,lateral decubitus ,or jack knife position.The most 
comfortable position is likely to be the position in which the 
anaesthesiologist can perform the procedure in the smoothest and fastest 
way. 
 Most commonly used position is lateral decubitus position because it 
is less dependant on a well trained assistant and allows administration of 
sedation during procedure.Patients back should be positioned at and 
parallel to the edge of the bed or operating table so that the patient is 
within easy reach of  the anaesthesiologist. The knees should be drawn 
towards the chest, and the neck should be in neutral or flexed position.The 
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patient should be asked to actively curve the lower back in order to flex the 
lumbar spine. 
 The sitting position allows for easier recognition of 
midline,especially in obese patients or those with scoliosis.When placing 
patients in this position a stool can be provide as a foot rest and a pillow 
placed in the lap.The assistant then maintains the patient in a vertical plane 
while flexing the patient’s neck and placing the patient’s arms over the 
pillow to open up the lumbar space. 
 
 
 
 
 
 
 
FIG 3a: LATERAL DECUBITUS POSITION 
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FIG 3b: SITTING POSITION 
6.SUPPLIES AND EQUIPMENTS:  The ability to efficiently and safely 
initiate epidural anaesthesia depends on having the right equipment 
immediately available.Commercial epidural trays containing disposable 
equipements are available.Epidural anaesthesia usually involves placing an 
epidural catheter in the epidural space, allowing for continous anaesthesia 
or analgesia. 
EPIDURAL NEEDLE: 
  Epidural needles used in conjunction with epidural catheters 
are usually 17 or 18 gauge, allowing 19 or 20 gauge catheter to be threaded 
through them. Standard epidural needles are 9cm long.Epidural needles 
22 
have different tip designs. Tuohy and Husted designs have a curved tip 
with a lateral facing orifice.The Crawford needle has a forward facing 
orifice, which facilitates threading of the epidural cathetar if the needle is 
expected to enter the space at a more acute angle. 
 
 
FIG 4a: TUOHY’S EPIDURAL NEEDLE 
 
FIG 4b: CRAWFORD EPIDURAL NEEDLE 
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EPIDURAL  CATHETER: 
 Epidural catheters are made of plastic.There are two types of 
catheters: single and multi orifice.Single orifice catheters have one orifice 
in a single compartment at the tip, whereas the multiorifice catheters have 
a closed,bullet tip and several(usually 3) openings 0.5-1.5 cm from the 
tip.The ability to aspirate blood should the catheter tip be located 
intravascular is much easier in multiorifice catheters.The wire embedded 
arrow epidural cathetar is a single orifice catheter associated with less 
incidence of parasthesias and intravascular complications. Modern epidural 
catheters have centimetre markings along the catheter, usually between 5 
and 20cm from the tip. 
 
SYRINGES FOR LOSS-OF-RESISTANCE: 
 Syringes used for the loss of resistance technique to identify the 
epidural space were traditionally made of glass with a Leur-lock connector. 
Currently syringes made of plastic are used.The type of loss of resistance 
(LOR) syringe is largely a matter of preference. 
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TECHNIQUE  FOR  EPIDURAL ANAESTHESIA 9,10,11: 
 Two approaches are usually followed, they are midline or 
paramedian approach. Both the approaches are performed with patient in 
lateral decubitus or sitting posture. Pateint position during and after 
injection of  local anaesthetic drug  plays less of  a role in determining the 
final extent of sensory blockade, as gravity has little effect on the 
distribution of epidural anaesthetic solutions. 
 
MIDLINE APPROACH: 
It is the commonly used approach with greater accuracy and better 
success in normal patient. The patient is placed in lateral decubitus or 
sitting posture. The level of needle insertion is decided based on the 
segments to be blocked. After proper positioning, sterile skin preparation 
and drapping, a local anaesthetic skin wheal is raised at the point of needle 
insertion.The epidural needle is inserted in the midline with the dorsum of 
the anaesthesiologist’s non injecting hand resting on the back of the 
patient, with the thumb and index finger holding the epidural needle hub 
(Bromage grip).The epidural needle with stylet is passed through the skin 
wheal and subcutaneous tissue to the depth of supraspinous ligament. This 
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allows the needle to be advanced perpendicular to the long axis of the 
spine in the saggital plane 
The Needle is advanced through the supra spinous and inter spinous 
ligament(about 3cm depth) giving a gritty feel.At that point the needle sits 
firmly in the midline in the saggital plane with the stylet removed.If the 
needle shaft falls,the tip is still in the subcutaneous plane and not in the 
ligament. A lateral deviation implies the needle being deflected off by a 
spinous process. Various techniques have been described to identify 
epidural space but LOR to air or normal saline is commonly used, by using 
an LOR syringe. By  applying  constant pressure to the LOR syringe 
attached to the hub of epidural needle, loss of resistance can be appreciated 
once the needle tip pierces the ligamentum flavum and enters the epidural 
space. 
PARAMEDIAN APPROACH: 
This approach is indicated for patients whose spine cannot be flexed 
and positioned easily, patients with calcified ligaments, spinal deformities 
like kyphoscoliosis and while performing thoracic epidural. In paramedian 
approach, a skin wheal is raised 1cm lateral and 1cm caudad to the caudal 
edge of the cephalad spinous process.  
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The epidural needle is inserted 10 to 15 degrees off  the saggital 
plane in a cephalo- medial plane. If  the needle contacts the bone, it is 
redirected slightly ia cephalad direction. If bone is again contacted, but at a 
deeper level, the slight cephalad  angulation is continued and the needle is 
walked off the lamina into the ligamentum flavum. Paraspinous muscles 
are pierced by the epidural needle with little resistance before piercing the 
ligamentum flavum and entering the epidural space.  
 
 
FIG 5a: LOSS OF RESISTANCE TO NORMAL SALINE 
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FIG 5b: NEGATIVE PRESSURE SIGN(HANGING DROP) 
IDENTIFICATION OF EPIDURAL SPACE10,11: 
 Two classical methods have been described to identify the epidural 
space. 
a) Loss of resistance to air or normal saline-The Sicard,Dogliotti 
test: 
This technique is based on the fact that there is loss of resistance 
when needle enters the epidural space piercing the interspinous ligament 
and the ligamentum flavum. Either air or normal saline can be used to 
identify LOR. Recent evidences suggest several reasons for the superiority 
of saline compared to air.These include lower incidence of patchy epidural 
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blockade, pneumocephalus and PPDH if there is inadvertent dural 
puncture. Moreover using  LOR to saline makes the change in resistance to  
be more accurately transmitted to the anaesthesiologist’s finger as it is 
incompressible. But the problem is difficulty in differentiating  CSF from 
saline if the dura is punctured.Reported complications of  LOR to air 
includes air embolism, subcutaneous emphysema and nerve root 
compression. 
 Various mechanical aids  have been incorporated to facilitate the 
appreciation of LOR namely MACINTOSH’S needle with spring loaded 
stylet, BRUNNER and ILKE’S spring loaded syringe and ZELENKA’S 
“U” tube with ballon indicator. 
 
b) NEGATIVE PRESSURE SIGN: 
 Negative pressure in the epidural space can be appreciated by the 
Hanging drop sign of Gutterrez. By placing a drop of  liquid in the hub 
of the needle, slowly the epidural needle is advanced into the epidural 
space. Liquid is placed once the needle is placed in the interspinous 
ligament. As the needle advances into the epidural space the hanging drop 
of liquid will be sucked in due to the negative pressure in the epidural 
space. 
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 Various mechanical aids have been used to identify this negative 
pressure, namely ANEROIOD manometer, “U” tube manometer, 
ODOM’S indicator,BROOK’S indicator, ZORRAQUIN’S bulb indicator 
and DAWKIN’S gravity indicator. 
 
EPIDURAL TEST DOSE 9: 
 The traditional epidural test dose tests whether the epidural catheter 
is malpositioned in the blood vessel or the intrathecal space. A negative 
response to an epidural test dose does not guarantee the correct placement 
of the epidural catheter in epidural space, but rather decreases the 
likelihood that catheter tip is in a blood vessel or the intrathecal space. The 
intravascular and intrathecal test doses may either be combined in a single 
injection or divided. Intrathecal placement of the catheter is tested by 
injecting small subanaesthetic bolus dose of  local anaesthetic drug, low 
enough  so that there is minimal risk of  total spinal. Intravascular 
placement of a catheter is traditionally tested by injecting adrenaline or 
subtoxic doses of  local anaesthetics. 
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TABLE 1: 
COMBINED INTRAVASCULAR & INTRATHECAL TEST DOSE 
 
TEST DOSE 
COMPONENTS 
 
 
POSITIVE INTRA -
VASCULAR TEST 
DOSE 
 
POSITIVE INTRA -
THECAL TEST DOSE 
 
Lignocaine 1.5% 
with adrenaline 
1:200,000, 3ml 
 
Increase in HR by 20 
beats per minute 
 
Motor blockade by 3-5 
minutes 
 
Bupivacaine 0.25% 
with adrenaline 
1:200,000, 3ml 
 
Increase  in HR by 20 
beats per minute 
 
Motor blockade by 3-5 
minutes 
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TABLE 2a:INTRAVENOUS TEST DOSE: 
       TEST DOSE POSITIVE INTRVASCULAR EFFECTS 
LIGNOCAINE 100mg 
BUPIVACINE 25mg 
CHLORPROCAINE 90mg 
 
TINNITUS CIRCUMORAL NUMBNESS, 
DIZZINESS 
FENTANYL 100mcg DIZZINESS, DROWSINESS 
AIR 1 ml MILL WHEEL MURMUR OVER RIGHT 
HEART 
 
TABLE 2b:INTRATHECAL TEST DOSES: 
TEST DOSE POSITIVE INTRATHECAL EFFECT 
LIGNOCAINE 40-60 mg 
BUPIVACAINE 7.5 mg 
 
MOTOR BLOCKADE AT 3-5 MINUTES 
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COMPLICATIONS  RELATED TO EPIDURAL ANAESTHESIA: 
 
MAJOR COMPLICATIONS: 
 The major complications include direct trauma to nerves, systemic 
toxicity with inadvertent intravascular injection, subdural injection of 
drugs, total spinal with inadvertent dural puncture, epidural abscess, 
meningitis, epidural hematoma and  allergy to local anaesthetics. 
MINOR COMPLICATIONS: 
 The minor complications include backache, nausea vomiting, 
hearing loss, Horner Syndrome, pneumocepahlus, shivering, urinary 
retention and post dural puncture headache( PDPH). 
 
PHYSIOLOGY OF PAIN 12,13,14 
Pain is protective in nature. It immobilizes the injured part and 
prevents further damage. Pain pathway and the nociceptive input are not 
passively transmitted from the periphery to the brain. The nociceptive 
pathway is an afferent three-neuronal ascending system, with decending 
modulation from cortex, thalamus and medulla. Nociceptors are free 
endings located in skin and muscle, bone and connective tissues with cell 
bodies located in the dorsal root ganglia. 
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 The first order neurons that make up the dual ascending system have 
their origins in the periphery as A delta and polymodal C fibres. A delta 
fibres transmit first pain which is described as sharp or stinging in nature 
and localized, whereas the polymodal C fibres are more diffuse in nature 
and associated with affective and motivational aspects of pain. First order 
neurons synapse on the second order neurons in the dorsal horn primarily 
within laminas I,II and V, where they release excitatory amino acids and 
neuropeptides. Second order neurons include the nociceptive specific 
neurons NSR and WDR neurons, located in lamina I and lamina IV,V,VI 
respectively. 
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FIG 6a: THE PAIN PATHWAY 
 
FIG 6b: THE REXED LAMINAE 
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PAIN PROCESSING 14,15: 
 Tissue injury tends to fuel neuroplastic changes in the nervous 
system which results in both peripheral and central sensitization, clinically  
manifesting as allodynia and hyperalgesia. The four elements of pain 
processing include: 
1.Transduction 
2.Transmission 
3.Modulation (inhibition/augmentation of pain signals) 
4.Perception 
Transduction is the process by which noxious painful stimuli are 
converted into actional potential. Transmission occurs when the action 
potential is conducted through the nervous system via the first, second  and 
third order neurons which have their cell bodies in the dorsal root ganglion, 
dorsal horn and thalamus respectively. Modulation involves alteration of 
afferent neural transmission along the pain pathway, which may be 
augmentation or inhibition of pain signals. Augmentation of pain signals is 
manifestated as central sensitization which is a consequence of neuronal 
plasticity. Perception of pain is the final common pathway resulting from 
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integeration of painful input into the somatosensory and limbic cortices. A 
multi modal approach to pain therapy should target all four elements of 
pain processing pathway. Epidural analgesia is a critical component of 
multimodal preoperative pain management and improved patient outcome. 
 
THE GATE CONTROL THEORY OF PAIN: 
 The observation that there was no link between stimulus and pain 
reported, and that pain perceived was affected by physiological and 
psychological variables led Melzack and Wall(1965) to propose a gate 
theory of pain modulation which has subsequently been modified. 
 Large and small fibres input into spinal cord transmission cells and 
into the substansia gelatinosa( lamina II of Rexed).The transmission of 
impulses to the transmitter cells is controlled by a spinal gating system. 
The is in turn influenced by the relative activity in large or small fibres. 
Activity in large fibres tend to inhibit transmission whereas activity in 
small fibres tends to stimulate transmission(opens the gate). The large 
diameter fibres are not necessarily nociceptive afferents; flooding the 
dorsal horn with cutaneous touch and pressure sensation may close the gate 
for smaller nociceptive input. 
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FIG 7: GATE CONTROL THEORY OF PAIN 
 
PHYSIOLOGICAL SEQUELAE OF SURGICAL PAIN: 
The neuroendocrine response to surgical pain causes increased 
secretion of catabolic hormones like cotrisol, glucagon,  growth hormone 
and catecholamines, and decreased secretion of anabolic hormones. The 
sympathoadrenal response have detrimental effects on numerous organ 
systems. 
1. CARDIOVASCULAR  SYSTEM: Tachycardia, hypertension, 
increase in cardiac workload. 
2. PULMONARY  SYSTEM: Respiratory muscle spasm, decrease in vital 
capacity, atelectasis, hypoxia and increase in risk of pulmonary infection. 
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3. GIT: Postoperative ileus 
4. RENAL: Increased risk of oliguria and urinary retention. 
5.COAGULATION: Increased risk of thromboemboli 
6.IMMUNE SYSTEM: Impaired immune function 
7.PSYCHOLOGICAL: Anxiety, fear, frustration resulting in poor patient 
satisfaction. 
 
ASSESSMENT OF PAIN 16 : 
“Pain is what a patient says it is” a maxim first attributed to Dr. John 
Bonica, the father of pain medicine. A variety of pain meseaurement scales 
exist that can be helpful yet are not definitive. 
UNIDIMENSIONAL SCALES: Numerical pain scale, the visual analog 
scale, the “faces” pain rating scale, activity tolerance scale. 
MULTIDIMENSIONAL SCALES: McGill Pain Questionnaire, Brief 
Pain Inventory, The Breakthrough Pain Questionnaire. 
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1.VERBAL PAIN SCALE: 
Verbal pain rating scales(none, mild,moderate,severe) have been used for 
many years and provide a simple tool to measure pain intensity.This scale 
may be used to measure treatment effect and may be more sensitive in 
detecting an improvement. 
 
2.VISUAL ANALOGUE  SCALE(VAS): 
VAS is on of the most widely used measures of pain intensity. Its 
consists of 10cm line marked at one end “no pain” and at the other end as 
“worst pain ever” or similar phrases.The patient is asked to indicate where 
on the line he or she rates the pain and numerical value is given simply by 
measuring the distance between no pain and patient mark. Its is 
conveniently presented as a slide rule with one side used by the patient and 
other side by the assessor. Advantage of VAS is its simplicity and it is 
independent of language. The main disadvantage is it doesn’t differentiate 
affective and sensory components. 
NUMERICAL PAIN RATING SCALE is similar to VAS, but with 
numericals 0-10, with 0 being “no pain” and 10 being “ worst pain ever” 
marked on a 10cm line.  
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3.McGILL PAIN QUESTIONNAIRE(MPQ): 
Unlike VAS, the questionnaire helps to differentiate affective and 
sensory components of pain, providing an accurate measurement of 
complete pain experience.It scales pain in three dimensions- sensory, 
affective and evaluative. Proven to be valid and reliable tool, MPQ is 
widely used in both clinical and research work. 
 
4.WEST HAVEN YALE PAIN INVENTORY:  
More brief and more classical in its psychometric approach. 
 
5.BRIEF PAIN INVENTORY: 
Valid and brief multidimensional pain measurement. 
 
6.MEMORIAL PAIN ASSESSMENT SCALE: 
Scales pain, pain relief and mood on visual analog scale. 
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FIG 8a: NRS:Numerical pain rating scale/VRS:Verbal pain rating  
scale/VAS:Visual analog scale 
 
 
 
 
 
FIG 8b: WONG BAKER FACE SCALE FOR PAIN ASSESSMENT 
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TREATMENT MODALITIES OF PAIN MANAGEMENT 4,17: 
PREEMPTIVE ANALGESIA: 
The importance of peripheral and central sensitization in pain pathway has 
fostered the concept of “preemptive analgesia” in patients undergoing 
surgery. This type of analgesia aims at effective analgesia prior to the onset 
of noxious stimuli such as surgical trauma. The mode of analgesia involves 
administration of effective opioids, NSAIDS or ketamine, central neuraxial 
blockade, wound infiltration with local anaesthetics. Experimental studies 
have shown that preemptive analgesia can attenuate peripheral and central 
sensitization to pain. Many studies have reported significant reduction in 
postoperative analgesic requirements in patients receiving preemptive 
analgesia athough few studies do not. 
MULTIMODAL APPROACH: 
It is defined as two or more  analgesics agents or techniques used in 
combination.The ASA,”Practice guidelines for acute pain management in 
perioperative setting” contains the following statement. 
 “During the administration of anaesthetics for surgery, the needs of 
many patients may best be met by taking advantage of combined effect of 
number of agents. Similarly, there is a growing conviction that a 
multimodality approach in providing perioperative analgesia has 
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advantages over single modality approach. The literature supports the use 
of two or more analgesic techniques(including non pharmacological 
methods) used in combination for the control of perioperative pain, 
especially when different sites and/or mechanisms of action are involved 
and/or when synergy of effect is achieved. The literature also indicates that 
multimodality approaches are associated with side effects no greater than 
those resulting from single analgesic techniques.” 
Postoperative analgesic modalities include oral and parenteral 
analgesics, peripheral nerve blocks, neuraxial blocks with local 
anaesthetics ,opioids, adjunctive techniques like TENS and physiotherapy. 
Selection of analgesic technique is based on three factors: patient, 
procedure and the setting(inpatient or outpatient). 
1.SYSTEMIC ANALGESIC TECHNIQUES: 
OPIOIDS: They exert their analgesic effect through mu-receptors in the 
brain and some peripheral receptors. They are used for moderate to severe 
pain. The major advantage is that there is no analgesic ceiling effect. 
Analgesic is limited by the development of tolerance and their side effects 
like nausea,vomiting, respiratory depression and sedation. Various routes 
of administration are subcutaneous, oral, transcutaneous, intramuscular and 
intravenous. Intravenous patient controlled analgesia circumvents the 
44 
 
problem of interpatient, intra patient variability in analgesic needs, 
variability in serum drug concentrations, administrative delays contributing 
to inadequate post operative analgesia. IV-PCA provides good patient 
satisfaction and provides superior analgesia but the patients used more 
opioids.  
NON OPIOIDS: 
NSAIDS: These drugs primarily act by inhibiting the synthesis of 
prostaglandins by cycloxygenese. NSAIDS are used as a sole agent in mild 
to moderate pain and along with opioids for moderate to severe pain. 
Perioperative use is associated with many side effects like decreased 
hemostasis, delayed bone healing and osteogenesis, renal dysfunction and 
gastrointestinal haemorrhage,  
KETAMINE: Perioperative subanaesthetic dose of ketamine reduces 
rescue anlagesic requirement or pain intensity. Low dose ketamine 
infusion does not cause hallucination or cognitive impairment, but causes 
side effects like dizziness, itching, nausea and vomiting which are 
comparable to opioids. Ketamine can be used intrathecally or epidurally, 
but racemic mixtures are found to be neurotoxic, hence neuraxial 
administration has been discouraged. 
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TRAMADOL: 
 Tramadol is a synthetic opioid with weak mu agonist activity. It is 
very effective in treating moderate postoperative pain and comparable in 
analgesic efficacy to asprin(650mg), codeine(60mg) or ibuprofen(400mg). 
Advantages of tramadol for postoperative analgesia imclude a relative lack 
of respiratory depression, major organ toxicity, depression of 
gastrointestinal motility and a low potential for abuse. It is contraindicated 
in patients on MAO inhibitors. 
REGIONAL ANALGESIC TECHNIQUES 18,19: 
Regional analgesic techniques can be an epidural technique or 
peripheral regional analgesic technique. The analgesia provided by 
regional analgesia techniques are superior to systemic  opioids and 
associated with decresed morbidity and mortality. It can be used as a single 
dose or continous epidural analgesia with opioid, local anaesthetics or local 
anaesthetic-opioid mixture. Use of local anaesthetic alone in epidural 
causes significant motor  blockade and hypotension when compared to 
LA-opioid mixture. Several randomized trials show that epidural lipophilic 
opioids act by systemic action as there is no difference in the plasma 
concentrations, side effects, pain scores between intravenous fentanyl and 
epidural fentanyl. When combined with local anaesthetic they provide 
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superior analgesia, limit regression of sensory blockade and decrease the 
dose of local anaesthetic used. 
 
BENEFITS OF EPIDURAL ANALGESIA: 
 Use of perioperative anaesthesia and analgesia especially with a 
local anaesthetic based analgesic solution can attenuate the 
pathophysiological response to surgery which may be associated with 
systemic opioids. A meta analysis of randomized data showed that 
perioperative use of neuraxial opioids reduced overall mortality by 
approximately 30%. Use of epidural analgesia can decrease the incidence 
of post operative gastrointestinal ,pulmonary and cardiac complications. 
Postoperative thoracic epidural decreases the incidence of postoperative 
MI by attenuating the stress response, hypercoaguability and causes 
redistribution of coronary blood flow. A meta analysis showed that post 
operative thoracic epidural with local anaesthetic based solutions 
decreased incidence of pulmonary complication when compared to 
intercostals blocks, wound infiltration, inter pleural analgesia and epidural 
opioids. Some studies haves shown earlier return of gastrointestinal 
motility in patients undergoing abdominal surgeries with local anaesthetic 
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based solution for epidural analgesia. Epidural analgesia provides greater 
patient satisfaction than systemic opioids. 
PERIPHERAL REGIONAL ANALGESIA: 
This can be used as a single injection or continous infusion and can 
provide analgesia superior than systemic opioids and greater patient 
satisfaction. 
OPIOIDS 20,21,22: 
The term opiate was originally used to refer to drugs derived from 
opium, including morphine, its semisynthetic derivatives, and codeine. The 
more general term opioid was introduced to designate all drugs, both 
natural and synthetic, with morphine like property, including endogenous 
opioids. 
ENDOGENOUS OPIOIDS AND OPIATE RECEPTORS 23,24: 
All of the endogenous opioids are derived from three prohormones: 
proenkephalin, prodynorphin and pro-opiomelanocortin each encoded by a 
separate gene. It was in 1970, a number of peptides  isolated from brain, 
spinal cord, plasma, GIT and placenta also had affinity for opiate receptors 
and had morphine like action. It was hypothesized that these peptides 
constitute an endogenous opiate system which normally modulate pain 
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perception, mood, hedonic behavior, motor behavior, pituitary hormone 
release, GIT motility, diuresis and modulation of respiratory responses to 
stimuli and drugs. These endogenous opioids are active in very small 
amounts and their action can be blocked by naloxone. Endogenous opioids 
are classified into three different families each derived form an unique 
large precursor polypeptide as mentioned above. 
ENDORPHINS: Most important in this family is the beta-endorphin, 
which has 31 amino acids. Its presence in spinal cord is debatable. Outside 
the CNS, beta-endorphins exists in GIT, placenta and plasma. 
ENKEPHALINS: Most important ones are methionine-enkephaline(met-
ENK) and leucine-enkephalin(leu-ENK), which are penta peptides. They 
have a wide distribution in the CNS such as the amygdala, globus pallidus, 
striatum, hypothalamus, thalamus, brain stem, dorsal horn. They have also 
been isolated from PNS such as the peripheral ganglia, adrenal medulla. 
They have been found to modulate analgesia through the modulation of 
substance P from the dorsal horn. 
DYNORPHINS: 
They primarily function as a neuromodulator and are found in the 
hypothalamo- neurohypophyseal axis. Dynorphins are also found to be 
distributed in other areas of CNS relevant to nociception like the 
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periaqueductal grey matter, limbic system, thalamus and dorsal horn of 
spinal cord. They are found to play a more important role  for nociception 
at the level of spinal cord than in the brain. 
 
OPIATE RECEPTORS 23,24: 
Opiate receptors are located in many areas of the CNS including the 
substansia gelatinosa of the caudal spinal trigeminal nucleus which carry 
pain fibres from face and hands via the cranial nerves 5,7,9 and 10.Within 
the spinal cord, opiate receptors have been demonstrated in the grey 
matter. The distribution of opiate receptors does not parallel the 
distribution of the endogenous receptors. The “C” fibre terminals have 
opiate receptors, but not the “A” fibres. Opiate receptors have also been 
demonstrated on the presynaptic sites on the dendrites of the second order 
neurons receiving “A delta” and “C” fibres. 
 The pharmacological action of  morphine and other opioids is 
mediated by their interaction with these opioid receptors. Radio-ligand 
binding studies have divided these opioid receptors into four categories: 
mu, kappa, delta and sigma. Each have a specific pharmacological profile. 
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Mu(morphine) receptor: 
 This receptor is named after the drug morphine,based on its binding 
affinity. It also exhibits high affinity to pethidine, fentanyl and its 
congeners. It is located both in the brain and spinal cord.The  highest 
concentration have been demonstrated in the periaqueductal gray region, 
thalamus,substansia gelatinosa, nucleus ambgious and nucleus tractus 
solitarius. Two sub types have been described: µ1 and µ2 mediating supra 
spinal analgesia and spinal analgesia respectively. 
Kappa(ketocyclazocine) receptor: 
 This receptor in named after its high affinity to ketocyclazocine. 
Two sub types: k1 and k3 are clinically important, mediating spinal and 
supra spinal analgesia respectively. Activation of kappa receptor causes 
mild to moderate analgesia, ceiling respiratory depression, dysphoria, 
hallucination, miosis, sedation and physical dependence. 
Delta receptor: 
 This receptor has affinity towards enkephalins and is present in both 
spinal cord(dorsal horn) and brain(limbic area). Activation of the receptor 
causes analgesia, respiratory depression, affective behavior, reduced GI 
motility. Delta receptors mediate spinal analgesia predominantly but the  
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affective component is mediated through supra spinal receptors in the 
limbus. The proconvulsant action is more prominent in delta receptor 
agonists. 
 
Sigma receptor: 
 It is no longer considered as opioid receptor because this receptor is 
neither activated by morphine nor blocked by naloxone. However certain 
drugs like pentazocine and butorphanol have been found to bind to sigma 
receptor. 
 
PHARMOCOLOGY OF DRUGS 
BUTORPHANOL 25,26,27 
Butorphanol is a synthetic opioid agonist-antagonist, whose actions are 
found te be mediated through mu, kappa, and sigma receptors. It was found 
to have significant analgesic property, narcotic antagonistic property, 
reversibility with naloxone by Montonic in 1973, by studying the drug 
effect in animals and man. 
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CHEMICAL NATURE: 
 Butorphanol is a 3,14-dihydroxy morphinion, with nitrogen 
substitution. It is a synthetic compound of phenanthrene series existing 
physically as a water soluble crystal. One milligram molecular weight of 
salt is equivalent to 0.68mg of free base. 
CHEMICAL STRUCTURE AND FORMULA: 
C12H29NO2C4H2O6  (FIG 9) 
 
CHEMICAL NAME:  (-)17-(CLOBUTYLMETHYL) MORPHINAN-
3,14 –DIOL[S-(R*R*)]-2-3 DIHYDROXY IBUTANEDIOATE (1:1) 
(SALT) 
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PHARMACODYNAMICS:  
MECHANISM OF ACTION: 
  Butorphanol being a mixed narcotic agonist and antagonist, 
acts as a partial agonist or weak antagonist at mu receptor and strong 
agnoist at kappa receptor. Activation of these receptors causes both supra 
spinal and spinal analgesia, sedation, dysphoria with low abuse potential. 
 Other effects of butorphanol on CNS include respiratory depression, 
suppression of cough, stimulation of emetic centre, miosis and sedation. 
Other effects are alteration in the cardiovascular resistance and 
capacitance, bronchomotor tone, GI motility and bladder sphincter activity. 
POTENCY: 
The analgesic potency of butorphanol can be compared with the gold 
standard opioid analgesic morphine. 
TABLE 3: POTENCY OF BUTORPHANOL 
 
DRUG 
AGONISTIC 
POTENCTY 
BUTORPHANOL:OTHER 
OPIOID 
ANTAGONISTIC 
POTENCY 
BUTORPHANOL:OTHER 
OPIOID 
PENTAZOCINE 20:1 10-30:1 
MORPHINE 5:1  
PETHIDINE 30-40:1  
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EQUIPOTENT ANALGESIC EFFECT: 
BUTORPHANOL 2mg = 10mg morphine = 40mg pentazocine = 80mg 
pethidine Following  intra muscular   injection of butorphanol, rapid 
absorption occurs and peak plama levels are attained by 20-40minutes. 
After nasal administration mean peak blood levels of 0.9-1.4 
microgram/ml is attained by 30-60minutes. 
PHARMACOLOGICAL EFFECTS: 
 Butorphanol blocks pain impulses at specific sites in brain and spinal cord. 
 Sedation with butorphanol is commonly noted at doses of 0.5mg and 
above. 
 Butorphanol in doses of about 10-12mg iv over 15mins produces narcosis. 
 Because of its affinity to kappa receptor, butorphanol produces unpleasant 
psychomimetic effects in some individuals. 
 Butorphanol in doses of 1mg and above through any route produces nausea 
and vomiting. 
 In individuals with significant respiratory dysfunction, 2mg of butorphanol 
intravenously causes respiratory depression  to a degree comparable to 
morphine. At higher doses, the magnitude of  respiratory depression 
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doesn’t increase due to ceiling effect,but the duration is prolonged 
significantly. 
 Subanalgesic doses exhibit antitussive effects in animal studies. 
 Effects on CVS: Analgesic doses of butorphanol in patients with cardiac 
dysfunction is found to increase pulmonary artery pressure, left ventricular 
end diastolic pressure(LVEDP), thereby causing an increase in cardiac 
workload. At higher doses, it causes increase in HR and BP due to increase 
in endogenous plasma catecholamines. So the use of butorphanol is not 
recommended in the presence of congestive heart failure and myocardial 
dysfunction. 
PHARMACOKINETICS: 
 Butorphanol is metabolized in liver extensively, which is 
qualitatively and quantitatively similar by intravenous ,intra muscular or 
nasal administration. Butorphanol shows extensive first pass metabolism 
and its oral bioavailability is 5-17% and so no oral formulation is  
available. 
 Hydroxyl butorphanol is the major metabolite of  butorphanol, while 
norbutorphanol in small amounts is also produced.Both of these 
metabolites have been detected in plasma following administration of  
butorphanol, with norbutorphanol in trace amounts. Elimination half life of 
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hydroxybutorphanol is 18hrs, therefore there is considerable drug 
accumulation when dosing is done to achieve a steady state concentration. 
Elimination occurs by faeces and urine. When H3 labelled butorphanol is 
administered to normal subjects 70-80% of  drug metabolite is recovered in 
urine, where 5% is recovered as butorphanol;40% is eliminated in the urine 
as hydroxybutorphanol and less than 5% is eliminated as norbutorphanol. 
The elimination half life of butorphanol is increased in elderly. In patients 
with creatinine clearance less than 30ml/min, the elimination half life is 
approximately double  as compared to 5-8hrs in normal subjects. 
Serum protein binding of  butorphanol is 80%, volume of distribution is 
305-901L and total body clearance is 52-154L/hour. 
THERAPEUTIC USES: 
Butorphanol is used: 
 As a preanesthetic medication 
 To supplement balanced anaestheisa 
 Transnasally for migraine 
 For post operative analgesia 
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PRECAUTIONS & CONTRANDICATIONS: 
Butorphanol should be used with caution in: 
 Patients with respiratory dysfunction-COPD, Bronchial asthma 
 Patients with hepatic and renal impairment 
 Patients with increased CSF pressure and  head injury 
 Patients with cardiac disease 
 Opioid dependant patients 
DRUG INTERACTIONS: 
 Butorphanol when used along with CNS depressants like 
alcohol,barbiturates,tranquilizers, antihistamines, may cause prolonged 
CNS depression. When used, lowest possible dose titrated to effect should 
be given and frequency of dosing should  be reduced. Currently its 
interaction with monoamino oxidase (MAO) inhibitors is reviewed. 
SIDE EFFECTS: 
The side effects of butorphanol are: 
 Drowsiness, confusion 
 Hallucinations, dysphoria 
 Hypotension 
 Nausea, vomiting 
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 Respiratory depression 
 Urinary retention 
 Pruritis 
 Hypersensitivity 
 Tolerance 
FENTANYL 28 
Fentanyl was first synthesized by Dr. Paul Janssen in 1960. It is a µ  
receptor agonist approximately 100 times more potent than morphine. It is 
a highly lipid soluble phenylpiperidine derivative and a synthetic opioid 
with low molecular weight. It is a safe and rapidly acting opioid available 
in parenteral and also in transdermal , aerosolized formulations.  
 
STRUCTURAL  FORMULA: 
 
 
  
 
FIG 10: STRUCTURAL FORMULA OF FENTANYL 
CHEMICAL FORMULA: C22H28N2O.C6H6O7 
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PHYSICAL PROPERTIES: 
 Fentanyl is available as a sterile solution of fentanyl citrate in water 
for injection(2ml ampoule containing 100mcg of fentanyl). It is clear with 
pH 4-7.5, pka 8.4 and should be stored at a temperature of less than 40 
degree celsius. 
MECHANISM OF ACTION: 
 Primarily a µ receptor agonist, fentanyl has an analgesic potency 
greater than morphine, pethidine and alfentanyl. Its principle site of  
interaction is the µ receptors located at the supraspinal sites. Fentanyl also 
binds  with the kappa receptors in the spinal cord to a  much lesser degree. 
 
PHARMACOLOGICAL EFFECTS: 
1.Cardiovascular system: 
a.Heart rate: 
 Fentanyl causes decrease in heart rate, due to stimulation of central 
vagal nucleus. Its action is  dependant on dose and speed of injection. 
Fentanyl is a potent stress response attenuator and acts  by decreasing the 
central sympathetic outflow. 
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b. Cardiac electrophysiological effects: 
 Fentanyl slows AV conduction, prolongs R-R interval, AV node 
refractory period and duration of purkinje fibres action potential. 
c. Blood pressure: 
 Centrally mediated reduction in sympathetic vasoregulatory flow,  
decreases systemic vascular resistance, causing minor reductions in blood 
pressure ,often associated with bradycardia. 
2.Respiratory system: 
 Fentanyl causes dose dependant respiratory depression. Respiratory 
rate,tidal volume and resting minute voulume are decreased. Fentanyl 
blunts the response to hypoxia and hypercapnia. 
3.CNS: 
 Fentanyl produces no change or modest reductions in cerebral blood 
flow and cerebral oxygen consumption. 
5.GIT: 
Fentanyl decreases the intestinal motility, causing constipation. It 
can  increase the tone of sphincter of  Oddi , there by increasing the 
pressure in biliary tract producing pain. 
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6.Muscle tone: 
 Fentanyl increases the muscle tone, causing rigidity which 
frequently occurs following iv induction with larger dose. But neuraxial 
administration of fentanyl is not associated with such effects. 
 
PHARMACOKINETICS: 
  Intravenous administration of a single dose of fentanyl has a faster 
onset and shorter duration of action than morphine. Although the onset is 
rapid there exists a a time lag between peak plasma concentration and peak 
slowing of  EEG. This is because of a delay in effect site equilibration time 
between blood and brain for fentanyl which is 6.4minutes. Greater lipid 
solubility enhances passage across blood brain barrier causing a greater 
potency and onset of action. Fentanyl has a rapid redistribution to inactive 
tissues like fat, skeletal muscle with associated decrease in plasma 
concentration, contributing to shorter duration of action. Fentanyl 
undergoes first pass pulmonary uptake, therby lungs acting as an inactive 
storage site. 
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METABOLISM: 
  Fentanyl undergoes extensive first pass metabolism by N-
demethylation producing norfentanyl, hydroxylproprionyl fentanyl and 
hydroxyproprionyl norfentanyl. Norfentanyl is structurally similar to 
normeperidine and the principle metabolite in humans.  It is excreted in 
kidneys and can be detected in urine upto 72hrs following a single dose. 
ELIMINATION ½ LIFE AND CONTEXT SENSITIVE ½ LIFE: 
  Elimination half  life is 3.1- 6.6hours, although its duration of action 
is short. This is due to its larger volume of distribution.
.
As the duration of 
continuous infusion of fentanyl increases beyond 24hours, the context 
sensitive half  life increases. It  is 200minutes after 4hours of stoppage of 
infusion. This is due to saturation of inactive tissues and return of drug to 
plasma from  peripheral compartment.
 
 
CLINICAL USES: 
Fentanyl is used, 
 In the prevention of surgery induced stress response 
 In labour analgesia 
 As a sole agent for surgical anesthesia 
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 As transdermal patch preoperatively  to allay anxiety and facilitate 
induction of  anesthesia. 
 In post operative pain relief. 
It is used clinically in a wide range of doses and through different 
routes. Analgesic dose of fentanyl is 1-2mcg/kg iv. In doses of 2-
20mcg/kg, fentanyl has been administered as iv adjuvants to inhalational 
anesthetics as an attempt to blunt intubation response. Large doses of 
fentanyl has been used as sole anesthetic because of its minimal effect on 
CVS, lack of histamine release and potent stress response suppression. 
Intrathecal/epidural administration of fentanyl produces rapid and 
profound analgesia. 
CONTRAINDICATIONS: 
 Patients on MAO inhibitors within previous 24hrs 
SIDE EFFECTS: 
The side effects of fentanyl include: 
 Bradycardia 
 Hypotension 
 Pruritis 
 Urinary retention 
 Respiratory depression 
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 Occular dysfunction 
 Sexual dysfunction 
 Hypersensitivity and anaphylaxis. 
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REVIEW OF LITERATURE 
 
The discovery of spinal opioid receptors and the subsequent 
development of the technique of epidural and intrathecal opioid 
administration is undoubtedly, one of the most significant advances in 
pain management in the last three decades. Spinal opioids can provide 
profound postoperative analgesia with fewer central and systemic adverse 
effects than with opioids administered systemically. 
Opiate receptors were identified in the CNS in 1973 by Pert and 
Synder and in 1977 large populations of these receptors were localized in 
the dorsal horn of the spinal cord. These observations, coupled with the 
discovery of endogenous opioids, led to animal studies that demonstrated 
that intrathecal administration of opioids produces analgesia29. 
Resill SI et al., in 1976 has described Visual Analogue Scale which  
is the easiest way to measure the intensity of pain.It is simple to use, 
efficient and can be analyzed quickly. It is a very sensitive way to assess 
intensity of pain. VAS can measure efficiency of analgesia by a particular 
analgesic by noting the scores before and after treatment, but the main 
drawback of VAS is that it assumes pain to be one-dimensional and 
 
66 
 
measures only the intensity of pain, whereas the nature, location and 
psychosocial aspect of pain are not taken into consideration30 . 
Behar in 1979 first reported the effective use of epidural opioids in 
humans. This initial study provided evidence that opioids reached the 
spinal fluid very rapidly and that analgesia could be obtained in the 
absence of “analgesic blood concentrations”. Since other neurological 
functions, including sympathetic vasoconstrictor responses were intact, 
the term ‘selective spinal analgesia’ was suggested 31. 
In 1979, Ameer B, Slater FJ reviewed chemistry, pharmacology, 
uses, side effects, pharmacokinetics and dosage of butorphanol tartrate. 
When administered IM or IV, butorphanol tartrate appears to be as 
effective for relieving moderate to severe pain as are morphine, meperidine 
and pentazocine. Butorphanol produces sedation more commonly and at 
therapeutic dosages, depresses respiration as much as other narcotic 
analgesics. A limited number of long term clinical studies suggest a lower 
physical dependence liability with butorphanol than with other narcotic 
analgesics. Butorphanol’s cardiovascular effects are not completely 
understood, so morphine remains the drug of choice for pain associated 
with myocardial infarction 32. 
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Naulty MD et al., in 1984 in Harvard Medical School, Boston, had 
conducted a double blind randomized dose response study of epidural 
butorphanol in post caesarean delivery patients, using 1, 2, 4 or 6mg of 
butorphanol tartarate. After the injection, subjects were evaluated at 5, 10, 
15 and 30 minutes and then at 30 minutes intervals for at least 5 hours 
following the injection. The onset of sensory analgesia was defined as the 
time elapsed when the patients had no sensory blockade detectable by 
pinprick and the duration of analgesia was defined as the time elapsed 
when the patient experienced any pain (a pain score >0 on the linear VAS). 
A statistically significant (p< 0.01) prolongation of postoperative analgesia 
was seen withbutorphanol doses greater than 1 mg and increasing duration 
of analgesia seen with increasing dose. Finally, increasing doses of 
epidural butorphanol significantly decreased the amount of narcotic 
required in the first 24hrs. Somnolence (easily arousable with a quiet 
verbal stimulus) of mean duration of approximately 6hrs was the only 
significant side effect encountered. No patients reported pruritis, nausea, 
dysphoria or respiratory depression during the course of study 33. 
Naulty JS et al., in 1985 evaluated suitability of fentanyl for 
epidural use and the dosages required in the parturient in a double-blind, 
randomized manner in 30 ASA 1 patients following caesarean delivery. 
The patients (5 each group) were randomly assigned to receive 0, 12.5, 
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25, 50, 70, or 100 µg of fentanyl through the epidural catheter. Level of 
sensory block, motor block, and pain intensity was assessed. 50 µg of 
fentanyl produced pain scores of 0 within 9 min and 100 µg in 3-6 min. 
With Fentanyl 25 µg, mean duration of analgesia was 3 hrs and higher 
doses produced an increase of approximately 1.5 times 34. 
Mok et al., in 1986 evaluated the analgesic efficacy and safety of 
epidural butorphanol in comparison to epidural morphine, in patients with 
postoperative pain, in a double blind controlled design. Postoperatively 
patients were divided into 2 groups in a randomized, double- blind fashion. 
Group A patients received, epidural butorphanol 4 mg in 10 ml normal 
saline and patients in Group B received morphine 5 mg in 10 ml normal 
saline epidurally.The onset of pain relief with epidural butorphanol 
appeared at 15 minutes, peaked at 30 minutes and duration of action 
averaged 5.4 hours; whereas with epidural morphine onset of analgesia 
appeared at 25 minutes, with a peak effect at 1 hour and duration of action 
averaged 15.2 hours.This study concluded that epidural butorphanol 
appears to provide efficacious pain relief without much untoward effects in 
patients with post surgical pain 35. 
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WE Ackerman in 1988 in his study evaluated and compared the 
duration of analgesia and side effects of equipotent doses of fentanyl (a 
pure agonist), buprenorphine (an agonist - antagonist) and butorphanol (an 
agonist – antagonist).He used 50µg of fentanyl, 0.3mg of buprenorphine 
and 2mg butorphanol epidurally for comparison in postoperative pain 
relief. The duration of analgesia was defined to be from the time of 
epidural study solution injection until the patient experienced any pain (a 
score > 0 on a 0-10 verbal response scale). The duration of buprenorphine 
was longer (388.06 ± 54.6 min.) and that of butorphanol is (117 ± 36.4 
min.).Sedation incidence was higher with butorphanol and no nausea / 
vomiting, disturbances in micturation or respiratory depression were noted 
in any group 36. 
Maurice Lippmann in 1988 has reported a study utilizing epidural 
butorphanol 4mg for pain relief in non-obstetric patients after abdominal 
operations and showed that epidural butorphanol provided pain relief with 
rapid onset (15 minutes) but substantially shorter duration (5.6 hrs) than 
that of epidural morphine 5mg. With serial blood gas measurements, 
epidural butorphanol 4mg did produce statistically significant elevation in 
Paco2 even though no clinically significant respiratory depression (RR < 
10 breaths / min) was observed in these patients. They concluded that 
epidural butorphanol might be an interesting alternative to epidural 
morphine 37. 
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Catherine O Hunt et al., in 1989 used increasing doses of epidural 
butorphanol (1,2,3 mg) along with local anaesthetics (0.25% bupivacaine) 
in 42 term multiparous patients for labour analgesia administered during 1st 
stage of labour when cervix was 5cm dilated and had minimum VAS pain 
score. The time from injection of the drug  to complete pain relief (VAS –
0) was shortened by addition of butorphanol (21.3 ± 52 min in plain 
bupivacaine group, 16.5 ± 3.6 min with 1mg butorphanol, 6.9 ± 3.6min 
with 2mg and 6.3 ± 3.7 min with 3mg of butorphanol). The duration of 
complete pain relief was prolonged by addition of butorphanol. In the 
groups in which 2 and 3 mg butorphanol was used, the total dose of 
bupivacaine used was reduced by more than 50% in total requirement  
(p< 0.01) than that used in the control group. The incidence of 
somnolence increased with higher dose of butorphanol. No patients had 
nausea, hypotension and respiratory depression. Two patients who 
received butorphanol 2mg early in labour complained of dysphoria                   
(a recognized side effect of Kappa-opiate receptor agonist, more common 
with pentazocine) 38. 
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Table 2: Catherine O Hunt Study 
 
Dose of 
butorphanol 
Duration of Analgesia 
No butorphanol 59 ± 12.3 min. 
1mg butorphanol 67 ± 15.2 min. 
2mg butorphanol 137 ± 18.4 min. 
3mg butorphanol 220 ± 24.1 min 
 
Ackerman in 1989 compared the incidence of pruritis after epidural 
administration of opioid in a controlled study of post cesarean section 
population, the incidence of pruritis was highest among patient receiving 
morphine, second highest with epidural fentanyl.  
Table 3: Ackerman Study 36 
Opioid Dose Incidence 
of pruritis 
Duration of 
analgesia 
(min) 
  
n (15) % 
 
Morphine 5mg 9 60 932 ± 87 
Fentanyl 50µg 7 47 145 ± 38 
Buprenorphine 0.3mg 0 0 388 ± 55 
Butorphanol 1mg 1 7 97± 23 
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Salomaki TE et al., in 1991 compared epidural and intravenous 
fentanyl infusions for pain relief for the first 20 hrs after thoracotomy in 40 
patients, who were assigned randomly to receive either fentanyl epidurally 
and saline intravenously or fentanyl intravenously and saline epidurally in 
a double blind fashion. Patients reported similar median pain scores, but in 
the epidural group the required mean fentanyl infusion rate, plasma 
fentanyl concentrations, incidence of nausea and sedation were less and 
respiratory functions were better preserved. Thus they found that there is 
clinical advantage of the epidural infusion over the intravenous infusion of 
fentanyl 39. 
Lytle SA et al., in 1991 did a retrospective analysis of 133 patients 
who received fentanyl for postoperative analgesia 5µg/ml as continuous 
epidural infusions. 59.3% of the patients did not receive any additional 
narcotics but 26.3% did.The side effects were less and respiratory 
depression did not occur. Urinary retention occurred in one patient, pruritis 
in 4% and nausea in 25.5%. They shown that epidural fentanyl provides 
good to excellent pain relief with minimal side effects 40. 
Quisqueya T et al., in 1991 compared epidural butorphanol (1, 2 and 
4mg) and morphine (5mg) for post caesarean section analgesia. Each dose 
of butorphanol produced greater pain relief than morphine at 15, 30, 45 
and 60min (p<0.05). At 90 min and two hours each dose of butorphanol 
and morphine produced similar pain relief. The time of onset of epidural 
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analgesia following butorphanol was more rapid than following morphine 
and 14, 22 and 17% of patients treated with butorphanol 1, 2 and 4mg 
respectively had not requested supplemental medications at eight hours. 
They concluded that epidural butorphanol is safe and effective in providing 
postoperative analgesia and may be particularly useful in clinical situations 
where, 
1. A prompt onset and / or limited duration of analgesic action may be 
indicated. 
2.  Epidural patient – controlled Analgesia (PCA) is used.41 
In 1991, Palocios et al., compared epidural butorphanol 1, 2, and 
4mg with epidural morphine 5mg for postoperative analgesia in 92 healthy 
term parturients who had undergone caesarean section under epidural 
anaesthesia in a randomized double blind study. Postoperative pain was 
assessed using a visual analog scale and recorded with heart rate, blood 
pressure and respiratory rate. The mean pain scores at 15, 30, 45, and 60 
minutes following each dose of butorphanol were significantly lower than 
corresponding values in the patients who received morphine.The time of 
onset of epidural analgesia following butorphanol was more rapid than 
following morphine. Pruritis occurred in only 1.4 percent of butorphanol 
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patients compared with 43 percent of the morphine patients. Thus the study 
concluded that epidural butorphanol is safe and effective in providing 
epidural analgesia 42. 
Kim DH, Kim TJ, Park NH in 2002 studied the efficacy of pain 
relief, adequate infusion dosage and the side effects of epidural 
butorphanol and compared with those of epidural fentanyl.  
In this study forty consenting, healthy, term parturients who had 
undergone Caesarean section under epidural lidocaine anaesthesia 
received 0.1% bupivacaine/ butorphanol 50 µg/ml (Group 1, n=20) or 
0.1% bupivacaine/fentanyl 5 µg/ml (Group 2, n=20) using patient 
controlled epidural analgesia (PCEA), were evaluated. RESULTS:The 
total amount of 48hr consumption was 19.4 mg (butorphanol) and 1546.8 
µg (fentanyl). There were no significant differences between the two 
groups in total infusion doses of the above drugs, VAS score and side 
effects. The potency ratio of fentanyl/butorphanol was 1/12.5. They 
concluded that both butorphanol and fentanyl were useful and safe drugs 
for PCEA for postoperative pain control and a combination of 
butorphanol and bupivacaine provided more economically effective 
analgesia. 
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Hwang KB, Chung CJ, Lee SC et al., in 2004 observed that epidural 
butorphanol produces effective analgesia with fewer side effects than 
morphine in obstetric patients. The analgesic efficacy and side effects of 
epidural butorphanol were compared with epidural fentanyl for patient 
controlled epidural analgesia (PCEA) after gastrectomy. After obtaining 
patient consent, 75 patients undergoing elective gastrectomy were 
randomly allocated to epidural butorphanol and epidural fentanyl groups. 
An epidural catheter was introduced at the T7-8 or T9-10 intervertebral 
spaces before operation. Postoperative analgesia was provided using a 
PCEA with either fentanyl 5µg/ml or butorphanol 50µg/ml in a 0.05% 
bupivacaine solution. The PCEA was set to deliver a bolus of 2 ml, with a 
lockout interval of 10 min and no basal infusion. PCEA consumption, pain 
intensity using a visual analog score (VAS), patient's satisfaction to PCEA 
and side effects were evaluated. No significant difference in PCEA 
consumption, VAS pain score, or patient's satisfaction to PCEA was found 
between the two groups. The incidence of pruritis in the butorphanol 
group was less than that in the fentanyl group (P < 0.05). The study 
concluded that PCEA with butorphanol provided similar postoperative 
analgesia with less pruritis than fentanyl in patients undergoing 
gastrectomy. 
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Premila Malik, Chhavi Manchanda, Naveen Malhotra in 2006 
conducted a study to assess and compare the safety and efficacy of 
postoperative analgesia with epidural butorphanol and fentanyl. The 
prospective, randomized double blind study was conducted in 60 patients, 
aged 20-60 years, belonging to ASA physical status class I or II and 
scheduled for elective orthopaedic hip or lower limb surgery to assess the 
safety and efficacy of postoperative analgesia with epidural butorphanol 
compared with epidural fentanyl. All the patients were administered 
combined spinal epidural anaesthesia. Patients were randomly allocated to 
two groups: Group A (n=30) - epidural butorphanol (2 mg) followed by 
top up doses of 0.5 mg was administered for postoperative analgesia and 
Group B (n=30) - epidural fentanyl (50 µg) followed by top up doses of 15 
µg was administered for postoperative analgesia.The timing of incremental 
doses, interval between injections and total dose of analgesic drug given in 
24 hours were recorded. There were no significant changes in pulse rate, 
systolic blood pressure, diastolic blood pressure, respiratory rate and 
peripheral arterial oxygen saturation in the two groups at different time 
intervals throughout the 24- hours study period (p>0.05).The duration of 
postoperative analgesia was longer and pain relief clinically better in 
butorphanol group. The sedation scores remained significantly higher in 
butorphanol group at all postoperative time intervals over 24 hours 
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(p<0.05). The incidence of nausea and pruritis was higher in epidural 
fentanyl group (p<0.05). They concluded that both butorphanol and 
fentanyl are effective and safe drugs for postoperative epidural analgesia 
with minor side effects 44. 
Gough JD et al., in 1988 in their study for postoperative pain relief 
tried a loading dose of epidural fentanyl of 1.5 µg/kg in 10 ml of sterile 
solution followed by continuous infusion. Range of mean (SD) of cardio-
respiratory variables were found to be 84(2)-95 (18) beats/min for H.R., 
121 (19)-133(14) mm Hg for systolic arterial pressure, 70(10)- 76 (10) mm 
Hg for diastolic arterial pressure and 21 (3)-23 (4) / min for respiratory 
rate.Their study concluded that 1.5µg/kg of fentanyl provided better 
hemodynamic stability in the postoperative period . 
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MATERIALS AND METHODS 
This study is a comparative and prospective study conducted at Thanjavur 
Medical College. After obtaining clearance from institutional ethical 
committee and informed consent, a total of 60 patients of either sex aged 
between 20-60years  belonging to ASA physical status I &II scheduled for 
elective lower abdominal surgeries were randomly selected. 
INCLUSION CRITERIA: 
 Patients aged between 20-60yrs 
 Weighing between 40-70kgs 
 Both male and female 
 ASA grade I&II 
 Patients undergoing elective lower abdominal surgeries 
   EXCLUSION CRITERIA: 
 Pregnant women 
 Patient with h/o cardiac and respiratory disorders 
 Patient with h/o hepatic and renal diseases 
 Patient with h/o convulsions, neurological deficits 
 Spinal deformities and psychiatric diseases 
 ASA grade III & IV 
 Coagulopathies and patients with infection at the puncture site. 
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METHODOLOGY 
 60 patients posted for elective lower abdominal surgeries were 
randomly selected for the study. All patients were thoroughly examined 
and investigated preoperatively one day before surgery and explained 
about the anesthetic technique. Routine preoperative investigations were 
done. All the patients were educated about the verbal numerical pain scale 
for assessment of  pain. 
Grading  of  post operative pain is done using Visual analog 
Scale(VAS).The patient will be asked to quantify their pain using VAS 
pain scale, giving a score of 0 to10, with 0- indicating no pain  and 10 
indicating the worst possible pain. 
Written informed consent was obtained. All patients received 
premedication at 10p.m on the night before surgery with Tab. Alprazolam 
0.25mg  and Tab. Ranitidine 150mg and thereafter advised nil per oral. 
 On the day of surgery patients were shifted to the operating room, 
and multiparameter monitors were connected. The base line heart rate, 
SpO2  and blood pressure(systolic, diastolic and MAP) were recorded. An 
18G iv cannula was inserted and patients were preloaded with  10ml/kg of  
Ringer lactate over 15-30minutes prior to epidural block.  
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The anaesthesia machine, airway equipments and emergency drugs were 
kept ready. 
 Patients were positioned in right lateral decubitus posture. 
Observing sterile precautions  L3-L4 space was identified. Skin was 
infiltrated with local anesthetic inj. 1% lignocaine 2ml. Epidural space was 
identified with an 18G Tuohys needle, by using loss of resistance to air 
technique and a 19G epidural catheter was inserted  about 5cms into the 
epidural space and secured in place. Throughout the procedure patient’s 
vitals were monitored. 
` A test dose of 3ml of 1.5% lignocaine with adrenaline(1:2,00,000) 
was given to rule out intravascular or intrathecal placement of the catheter. 
The patient was made to lie supine. Five minutes after test dose, 
confirming the absence of intrathecal or intravascular placement, 20ml of 
study drug was injected through epidural catheter depending on the study 
group.  
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Patients were divided into two groups: 
Group BB 
 30 patients 
Bupivacaine with butorphanol group 
0.5% bupivacaine (18ml) with 1ml of 1mg 
butorphanol  (preservative free) with 1ml of sterile 
normal saline  to make a total of 20ml. 
Group BF 
30 patients 
Bupivacaine with Fentanyl group  
0.5% Bupivacaine 18ml with 2ml(100mcg) of 
fentanyl (preservative free). 
 
  
All patients were given oxygen at 5L/min through face mask. 
No intravenous analgesics or sedation were administered during the 
surgery. 
The time of injection of study drug  was noted  at  “0” time.The drug was 
injected approximately at the rate of 1ml/second and the height of sensory 
blockade was determined by eliciting pin prick test 
In the perioperative period the following parameters were studied. 
1.Vital parameters such as HR,BP, SPO2,RR were continuously monitored 
every 5mins for the first 15mins and then onwards every 15mins 
throughout the intraoperative period and every ½ an hour in the post 
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operative period for 2hours. Intraooperative hypotension if any was treated 
with iv fluids, O2 supplementation  and titrated doses of ephedrine 3-6mg 
or mephenteramine 3-6mg iv. Bradycardia if any was treated with Inj. 
Atropine. 
2.Onset of  analgesia is the time taken from injection of local anaesthetic 
solution upto loss of  pin prick sensation in any dermatome. 
3. Completion of  analgesia is the time taken from the initial onset of 
analgesia upto the time when analgesia attained its maxium dermatome 
level, with no further rise  for 5mins. 
4. Quality of analgesia was graded as follows: 
 Good- No complaint of pain or discomfort during the procedure 
 Fair-Pain or discomfort felt only during specific stages of 
procedure, like traction on viscera/peritoneum. 
 Poor-Pain during surgery and needed top up with epidural local 
anaesthetic solution. 
5. Duration of analgesia is the time taken from the onset of analgesia upto 
the time when VAS reached a score of 5. 
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 6.Sedation score was assessed using subjective sedation score: 
0 awake, conscious, no sedation to slightly restless 
1 calm and composed 
2 awakens on verbal commands 
3 awakens on gentle tactile stimulation 
4 awakens only on vigorous shaking 
5 unarousable 
 
POST OPERATIVE OBSERVATIONS: 
The following parameters were observed in the post operative period: 
1.Pain score – VISUAL ANALOGUE SCALE, every hour till 8hrs. 
2.Vitals were recorded at the same time intervals as the pain score. 
When the VAS score reached 5, rescue analgesia was given through the 
epidural catheter and the study in the patient ceased.Complications like 
nausea, vomiting, urinary retention,headache, pruritis and respiratory 
depression if any were noted and treated accordingly. 
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OBSERVATION AND RESULTS 
The data collected  was subjected to statistical analysis using 
Statistical Package for Social Sciences. Chi-square test and the student ‘t’ 
test was used to test the significance of difference between the two groups. 
A ‘p’ value <0.05 was taken to denote a significance. 
 
TABLE 4: COMPARISON OF AGE 
Both the groups were comparable with respect to demographic profiles like 
age, sex, weight. 
 
GROUP 
 
MEAN(years) 
 
S.D± 
 
Statistical 
significance 
 
BB 
Group(n=30) 
 
41.37 
 
6.071 
 
 
T= -1.96  Df = 48 
0.8457> 0.05 
 
 
BF 
Group(n=30) 
 
41.63 
 
4.311 
 
Patients aged 20 – 60yrs were included in the study. The mean age is 41.37 
years  in BB group and 41.63 years in BF group. There is no statistical 
difference in the  age comparison between the two groups. 
85 
 
 
 
GRAPH 1: AGE COMPARISON 
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TABLE 5: SEX DISTRIBUTION 
 
SEX 
 
 
BB GROUP 
N = 30 
 
 
BF GROUP 
N = 30 
 
 
 
Statistical signifiance 
 
 
MALE 
 
27(90%) 
 
28(92%) 
 
 
 
X2 = 0.758 Df = 1 
0.384 > 0.05  
FEMALE 
 
3(10%) 
 
 
2(8%) 
 
90% of patients in BB group are males, 92% in BF group are males. 10% 
in BB group are females and 8% in BF group are females. There is no 
statistical difference in sex comparison between the two groups. 
 
 
87 
 
 
 
 
GRAPH 2: SEX COMPARISON 
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TABLE 6:  COMPARISON OF HEART RATE 
TIME IN 
MINUTES 
GROUP BB GROUP BF 
STATISTICAL 
INFERENCE 
MEAN/MINS S.D MEAN/MINS S.D 
0 84.50 ±7.408 83.80 ±7.392 0.769>0.05 NS 
5 87.33 ±9.488 87.80 ±9.368 0.849>0.05 NS 
10 84.87 ±9.850 86.17 ±8.848 0.593>0.05 NS 
15 82.87 ±9.726 84.53 ±8.693 0.487>0.05 NS 
20 80.83 ±9.959 83.57 ±8.451 0.256>0.05 NS 
25 79.97 ±9.764 83.13 ±8.645 0.189>0.05 NS 
30 78.87 ±10.06 82.03 ±8.282 0.189>0.05 NS 
40 77.23 ±9.517 81.07 ±7.570 0.090>0.05 NS 
50 75.60 ±9.328 75.68 ±9.126 1.000>0.05 NS 
60 74.77 ±9.175 74.67 ±9.089 1.000>0.05 NS 
70 74.33 ±8.856 74.13 ±8.813 1.000>0.05 NS 
80 73.97 ±9.528 74.17 ±9.108 0.935>0.05 NS 
90 73.07 ±9.303 73.20 ±9.103 0.955>0.05 NS 
100 72.80 ±8.608 73.10 ±8.658 1.000>0.05 NS 
110 72.43 ±8.557 72.32 ±8.432 1.000>0.05 NS 
120 72.20 ±7.490 72.57 ±7.398 1.000>0.05 NS 
 
There is stastically no significant difference in mean heart rate from 5 
minutes to 120 minutes between the groups BB and BF. Mean heart in BB 
group was  75.60/min and BF group was 74.67/min. 
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GRAPH 3: COMPARISON OF MEAN HEART RATE 
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TABLE 7: CHANGES IN MEAN ARTERIAL BLOOD PRESSURE 
TIME IN 
MINUTES 
GROUP BB GROUP BF STATISTICAL 
INFERENCE MEAN/mmHg S.D MEAN/mmHg S.D 
0 92.7667 ±6.083 89.7000 ±7.278 0.969>0.05 NS 
5 90.8667 ±7.152 90.6667 ±8.035 0.919>0.05 NS 
10 87.6000 ±6.975 87.4000 ±7.686 0.918>0.05 NS 
15 85.2000 ±7.274 85.0667 ±7.965 0.996>0.05 NS 
20 83.4333 ±7.219 83.3667 ±7.880 0.973>0.05 NS 
25 82.1333 ±6.489 81.9333 ±7.248 0.911>0.05 NS 
30 80.5000 ±6.323 80.3333 ±7.018 0.923>0.05 NS 
40 79.6667 ±6.171 79.5667 ±6.382 0.951>0.05 NS 
50 78.8000 ±5.695 76 7.7333 ±5.976 0.965>0.05 NS 
60 79.0000 ±5.219 78.9333 ±5.426 0.961>0.05 NS 
70 80.3000 ±4.403 80.3000 ±4.587 1.000>0.05 NS 
80 81.1667 ±4.534 81.3000 ±4.617 0.911>0.05 NS 
90 83.2333 ±4.336 82.6667 ±4.412 0.618>0.05 NS 
100 84.0667 ±4.109 83.5333 ±4.116 0.617>0.05 NS 
110 86.1000 ±4.369 85.4333 ±4.272 0.550>0.05 NS 
120 87.2333 ±4.328 86.4333 ±4.264 0.474>0.05 NS 
 
There is statistically no significant difference in the mean arterial pressure 
from 5 minutes to 120 minutes between BB group and BF group. The 
mean arterial blood pressure in BB group is 83.4 mmHg±1.26(S.D.) and in 
BF group is 81.3 mmHg±1.05(S.D.). 
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GRAPH 4: COMPARISON OF MEAN ARTERIAL BP 
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TABLE 7: COMPARISON OF MEAN RESPIRATORY 
RATE/MINUTE 
TIME IN 
MINUTES 
MEAN/MINUTES S.D. ± STASTISTICAL 
INFERENCE GROUP 
BB 
GROUP 
BF 
GROUP 
BB 
GROUP 
BF 
0 13.4 13.7 1.042 0.868 0.286>0.05 NS 
5 13.7 13.2 0.069 0.695 1.000>0.05 NS 
10 14.9 14.2 1.709 1.092 0.064>0.05 NS 
15 14.6 14 1.401 1.050 1.000>0.05 NS 
20 13.7 13.8 1.250 0.924 0.967>0.05 NS 
25 13 13.4 1.188 1.072 0.176>0.05 NS 
30 12.8 12.9 1.156 1.033 0.558>0.05 NS 
40 12.2 12.6 1.104 0.932 0.170>0.05 NS 
50 12 12.5 1.080 0.937 0.492>0.05 NS 
60 12 12.1 1.082 0.791 0.499>0.05 NS 
70 11.9 11.83 1.172 0.647 0.684>0.05 NS 
80 12.0 12.2 0.932 0.839 1.000>0.05 NS 
90 12.1 12 1.074 0.909 0.606>0.05 NS 
100 12.3 12.1 0.994 0.937 0.426>0.05 NS 
110 12.2 12.4 0.935 0.865 0.392>0.05 NS 
120 12.3 12.5 0.927 0.858 0.390>0.05 NS 
 
There is statistically no significant difference in the mean respiratory rate 
from 5mins to 120mins between BB group and BF group. The mean 
respiratory rate in BB group is 12.6 and in BF group is 12.9. 
 
 
93 
 
 
 
 
GRAPH 5: MEAN RESPIRATORY RATE IN BB AND BF GROUPS 
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TABLE 8: COMPARISON OF MEAN SPO2 IN BB AND BF 
GROUPS 
TIME IN 
MINUTES 
GROUP BB GROUP BF STASTISTICAL 
INFERENCE MEAN 
% S.D. 
MEAN 
% S.D. 
0 98.5 ±0.507 98.5 ±0.504 0.799>0.05 NS 
5 98.4 ±0.502 98.5 ±0.501 0.769>0.05 NS 
10 98.4 ±0.500 98.4 ±0.502 0.748>0.05 NS 
15 98.3 ±0.479 98.3 ±0.504 0.434>0.05 NS 
20 98.2 ±0.450 98.2 ±0.479 0.581>0.05 NS 
25 98 ±0.365 98 ±0.450 0.302>0.05 NS 
30 98 ±0.183 98 ±0.365 0.656>0.05 NS 
40 98 ±0.101 97.9 ±0.183 0.321>0.05 NS 
50 98 ±0.263 97.9 ±0.183 0.570>0.05 NS 
60 97.7 ±0.365 97.8 ±0.346 0.477>0.05 NS 
70 97.6 ±0.485 97.6 ±0.498 0.125>0.05 NS 
80 97.6 ±0.508 97.6 ±0.490 0.305>0.05 NS 
90 97.8 ±0.379 97.7 ±0.449 0.356>0.05 NS 
100 97.8 ±0.345 97.8 ±0.345 1.000>0.05 NS 
110 97.8 ±0.365 97.8 ±0,182 0.656>0.05 NS 
120 97.9 ±0.253 98 ±0.101 0.155>0.05 NS 
 
There is no statistical significance in mean Spo2 from 5 minutes to 120 
minutes in between BB group and BF group. 
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GRAPH 6: TREND OF MEAN SPO2 IN BB AND BF GROUPS 
OVER 0 MINUTES TO 120 MINUTES 
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TABLE 9: SEDATION CHARACTERISTICS 
 
TIME IN 
MINUTES 
SUBJECTIVE SEDATION SCORE(% OF 
CASES 
 
STATISTCAL 
INFERENCE 
GROUP BB GROUP BF 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
30 
 
 
 
100   
 
 
 
 
85 
 
15  
 
 
 
 
 
 
0.001< 
0.05 S 
 
60  
 
 
 
100  
 
 
  
 
100 
 
 
   
 
0.001< 
0.05 S 
 
90  
 
 
 
100  
 
 
  
 
80 
 
20    
 
0.000< 
0.05 S 
 
120  
 
 
 
75 
 
25   
 
12 
 
32 
 
56 
 
 
 
 
 
 
0.003< 
0.05 S 
 
In group BB, 100%  patient  had  sedation score of 1 at 30 minutes, 
whereas in group BF 85% patients had a sedation score of 0 at 30 minutes. 
At 60,90and 120 minutes majority of the patients in group BB had a 
sedation score of 2 and 3, whereas in group BF the sedation score was 
1and 2. 
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TABLE 10: COMPARISON OF ONSET AND COMPLETION OF 
SENSORY BLOCK IN GROUP BB & BF 
 
 
 
 
 
 
  
 
PARAMETERS 
 
GROUP BB 
 
GROUP BF  STATISTICAL 
INFERENCE MEAN IN 
MINUTES 
 
S.D. 
MEAN IN 
MINUTES 
 
S.D. 
 
ONSET OF 
SENSORY 
BLOCK 
 
5.73 
 
1.48 
 
5.96 
 
1.67 
 
0.871>0.05 
 
Not Significant 
 
COMPLETION 
OF SENSORY 
BLOCK 
 
10.10 
 
1.26 
 
10.53 
 
0.89 
 
0.132>0.05 
 
Not Significant 
 
ONSET OF 
MOTOR 
BLOCK 
 
4.45 
 
0.30 
 
4.88 
 
0.30 
 
0.310>0.05 
 
Not Significant 
 
COMPLETION 
OF MOTOR 
BLOCK 
 
29.58 
 
1.04 
 
31.45 
 
0.91 
 
0.128>0.05 
Not significant 
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GRAPH 7: BLOCK CHARACTERISTICS 
 
There is no significant statistical difference in the time of onset of 
sensory and motor block, completion of sensory and motor block in 
between group BB and group BF. Mean onset time of sensory block, 
completion of sensory block,onset of motor block and completion of motor 
block  in group BB is 5.73minutes,10.1 minutes,4.45 minutes and 29.58 
minutes respectively. In BF group, mean time of onset of  sensory, 
completion of sensory block,onset of motor block and completion of motor 
block  are 5.96mins,10.53mins,4.88mins and 31.45 mins respectively. 
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TABLE 11: COMPARISON OF DURATION OF ANALGESIA  
 
PARAMETER 
 
GROUP BB 
 
GROUP BF 
 
STATISTICAL 
INFERENCE 
 
MEAN 
HOURS 
 
±S.D. 
 
MEAN 
HOURS 
 
±S.D 
 
DURATION OF 
ANALGESIA 
 
 
 
7.1 
 
 
 
1.008 
 
5.2 
 
1.080 
 
0.001<0.05 
SIGNIFICANT 
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GRAPH 8: DURATION OF ANALGESIA 
 
 
There is statistically significant difference in the duration of  analgesia 
between group BB and group BF. The duration of analgesia was longest 
with butorphanol group(5-9 hours; mean-7.1 hours), whereas in group BF 
was 3-9 hours, mean 5.2 hrs. 
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TABLE 12: THE MEAN POST-OPERATIVE PAIN SCORES(VAS) 
AT DIFFERENT TIME  INTERVALS  IN GROUP BB & GROUP 
BF 
 
TIME 
INTERVAL 
 
GROUP BB 
 
GROUP BF  STATISTICAL 
SIGNIFICANCE MEAN ±S.D. MEAN ±S.D. 
 
1 HR 
 
0.12 
 
0.71 
 
1.12 
 
0.45 
 
0.000<0.05 S 
 
2 HR 
 
0.61 
 
0.61 
 
1.48 
 
0.91 
 
0.008<0.05 S 
 
3 HR 
 
0.72 
 
0.60 
 
1.91 
 
0.56 
 
0.021<0.05 S 
 
4 HR 
 
2.18 
 
0.87 
 
3.06 
 
1.70 
 
0.001<0.05 S 
 
5 HR 
 
2.50 
 
1.17 
 
3.88 
 
0.96 
 
0.003<0.05 S 
 
6 HR 
 
2.51 
 
1.07 
 
3.96 
 
0.91 
 
0.012<0.05 S 
 
7 HR 
 
4.06 
 
0.61 
 
4.94 
 
0.56 
 
0.001<0.05 S 
 
8 HR 
 
5.00 
 
0.08 
 
5.51 
 
0.54 
 
0.44>0.05 NS 
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GRAPH 9: PAIN SCORES (VAS) IN GROUP BB & BF 
 
As shown in graph 9, the pain scores as assessed on VAS were low and 
remained low for a significant time in the post operative period in group 
BB when compared to group BF. 
 
 
 
 
0
1
2
3
4
5
6
1 HR 2 HR 3 HR 4 HR 5 HR 6 HR 7 HR 8 HR
P
A
IN
 S
C
O
R
E
(V
A
S
)
TIME INTERVAL
GROUP BB
GROUP BF
103 
 
 
 
GRAPH  10: QUALITY OF ANALGESIA 
 
Majority of the patients in both group BB and Group BF had good quality 
of analgesia. None of the patients required top up doses of  local 
anaesthetics intra operatively. 
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TABLE 13: 
COMPARISON OF SIDE EFFECTS BETWEEN GROUPS BB & BF: 
SIDE EFFECTS GROUP BB (n=30) 
GROUP BF 
(n=30) p Value 
Pruritis  1 
 
6 
 
0.353>0.05 NS 
Nausea/vomiting  1 
 
4 
 
0.671>0.05 NS 
Respiratory 
depression 
 
0 
 
0 
 
0 
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GRAPH 11: COMPARISON OF SIDE EFFECTS: 
 
 
 In group BB, 3.33% of patients had nausea/vomiting compared to 
13.33% of patients in BF group, whereas 3.33% of patients had pruritis in 
BB compared to 16.66% of patients in BF group. This was not statistically 
significant (p > 0.05). None of the patients in both the groups were 
reported to have respiratory depression. 
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DISCUSSION 
Opioids are being extensively used as adjuvants to local anaesthetics 
to improve the quality of  the  block and to produce dose-sparing effect. 
Epidural administration of various analgesics have gained popularity 
following the discovery of opioid receptors  in the spinal cord. The use of 
epidural techniques also offer the advantage of post-operative analgesia. 
There are a number of studies to prove the efficacy of adding opioids to 
local anaesthetics. Opioid receptors are found to be highly specific 
receptors  located in specific regions of  central nervous system and 
peripheral nervous system. The opioid receptors located in the dorsal horn 
of spinal cord mediate both pre and post synaptic effects modulating the 
nociceptive input without sensory or motor blockade. Epidural 
administration of opioids have found to be superior than intravenous or 
intramuscular injection of opioids. 
 Although in recent times various opioids have been used for post 
operative analgesia, earlier morphine and pethidine were the standard 
drugs, which were  associated with increased incidence of delayed 
respiratory depression and abuse potential.Stimulation of spinal opiate 
receptors produces spinal analgesia with lesser side effects.  
 
107 
 
Butorphanol a mixed opioid , with an agonist and antagonist action 
at µ receptor and an agonist action at kappa receptor, is found to produce 
potent analgesia with fewer side effects and very low abuse potential. It is 
highly lipid soluble and has greater affinity to opioid receptors, which 
contributes to its greater potency and efficacy. 
Fentanyl, being a synthetic opioid receptor agonist, is found to 
produce analgesia by binding to supra- spinal opioid receptors when 
administered into the epidural space. It is better retained in the epidural 
space because of its high lipid solubility. Following administration into the 
epidural space, systemic absorption occurs, but it has a shorter half life, 
hence there is less circulating plasma drug concentration. Epidural 
administration of fentanyl  is associated with reduced respiratory 
depression and  lesser incidence of side effects like nausea, vomiting and 
pruritis. 
 The present study is prospective ,randomized, comparative study 
done to compare the efficacy of butorphanol and fentanyl added as 
adjuvants to bupivacaine in epidural anaesthesia in lower abdominal 
surgeries with respect to intra operative hemodynamic stability and post  
operative analgesia. A total of 60 patients both male and female belonging 
to the age group of  20-60 years were studied, among which majority of the 
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patients were aged between 40-50 years and majority of the 60 patients  
underwent general surgery.  
During the preoperative assessment, the patients were clearly 
explained about the anaesthetic procedure and also educated about the 
assessment of  pain in the post operative period using VAS. Written 
consent was obtained from all the patients. At 10 pm on the night before 
surgery, all patients were premedicated with Tab. Alprazolam 0.25 mg and 
Tab. Ranitidine 150 mg and advised nil per oral from then 
onwards.Patients were randomly divided into two groups of 30 per group, 
Group BB- bupivacaine with butorphanol and Group BF- bupivacaine with 
fentanyl. All the surgeries were done under lumbar epidural anaesthesia 
with a total volume of 20 ml of study drug in each group. Intra operatively 
vital parameters like pulse rate, mean arterial blood pressure, oxygen 
saturation, respiratory rate were recorded every 5 minutes from the time of 
injecting the study drug upto 30 minutes and then onwards every 10 
minutes upto 120 minutes. Similarly the sedation score throughout the 
intra-operative period, the time of onset and completion  of sensory block, 
the time of onset and completion of motor block,side effects if any were 
recorded 
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There was no case of epidural failure and no patient required 
epidural top-up with local anaesthetics in the intra operative period. In the 
post- operative period  pain  was assessed using the VAS, every hour upto 
8hrs. 
 At the same time the vital parameters and side effects were also 
recorded and treated accordingly. When the VAS > 5, the patients were 
given rescue analgesia with Tramadol 100mg in 10ml of normal saline 
through the epidural catheter and study in that patient ceased and the 
duration of analgesia was noted. The duration of analgesia was 
significantly seen to be prolonged with bupivacaine- butorphanol group 
(BB) 
IN OUR STUDY: 
INTRA OP HEMODYNAMICS: 
In our study,the majority of patients were hemodynamically stable 
intra-operatively. Comparison of heart rate and MAP within the groups 
was done using paired ‘t’ test whereas comparison of heart rate and MAP 
in between the two groups was done using unpaired ‘t’ test. 
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The mean arterial BP in Group BB was 83.4 mm Hg± 1.26 (S.D ) 
mmHg and in group BF was 81.3mm Hg± 1.05 (S.D) mm Hg. The mean 
reduction in MAP was statistically insignificant between both the groups. 
In both groups  BB and BF, there was a fall from the baseline MAP of 92.7 
mmHg±6.08(S.D.) and 89.7 mmHg±7.27(S.D.) respectively to 78.8mmHg 
and 76.7mmHg at 40-50 mins time interval which was not statistically 
significant. 
  The mean pulse rate in Group BB was 75.6±1.35(S.D.)/min and in 
Group BF was 74.67±0.92(S.D.)/min. The statistical analysis showed that 
there was no significant difference between the two groups. 
 The mean respiratory rate in group BB was 12.6± 1.32(S.D.)/min 
and in group BF was 12.9±0.98(S.D.)/min. The statistical study showed no 
significant difference in the mean respiratory rate between the 2 groups.  
 Oxygen saturation (SPO2) maintained between 98-97% in both the 
groups. None of the patients in both the groups showed 
desaturation(SPO2<95%). 
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Our study can be compared to the following studies: 
Gough et al., in 1988 used epidural fentanyl 1.5µg/ kg body weight 
in 10ml of sterile solution and concluded that the range of mean(S.D) of 
cardio- respiratory variables like heart rate 84(±2) to 95(±18) beats/ min, 
systolic BP of 121(±19) to 133(±14) mm of Hg, diastolic BP of 70(±10) to 
76(±10) mm of Hg and RR of 14(±3) to 16(±4) / min varied negligibly 
from basal recordings. 
Premila Malik, Chhavi Manchanda, Naveen Malhotra et al., in 
2006 conducted a study to assess and compare the safety and efficacy of 
postoperative analgesia with epidural butorphanol 2mg and fentanyl 50µg. 
Their study showed that there was no significant changes in pulse rate, 
systolic and diastolic BP, RR and SpO2 in the 2 groups at different time 
intervals throughout the 24 hours study period (p> 0.05). 
SEDATION SCORES:  
Catherine O Hunt in her study has reported a higher incidence of 
sedation with epidural butorphanol and is a dose dependent side effect. In 
our study sedation scores were higher with butorphanol group as compared 
with fentanyl group.Mean value of subjective sedation score was 
1.00±0.06 in group BF and 3.0±0.64 in group BB. Majority of the patients 
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had mild sedation. The patients were awake but drowsy. This was 
statistically significant (p< 0.001).  
JS Naulty in his study noted that sedation was significant, but was 
of mild type (arousable with verbal response).72% of patients on epidural 
butorphanol 2mg had clinically significant sedation in a study by Therese 
K et al. 
Rutter DV et al., in 1981 reported that fentanyl 100µg for 
postoperative pain relief produced increase in sedation. 
 
ONSET AND COMPLETION OF SENSORY BLOCK: 
In our study the onset and completion of analgesia was hastened 
with the addition of butorphanol and fentanyl. But there was no 
statistically significant difference detween the two groups. Addition of 
1mg butorphanol to 20ml 0.5% bupivacaine reduced the latency of onset of 
analgesia to 5-9mins and completion of analgesia occurred earlier(9-14 
mins, mean 10.10 mins). In BF group also the onset of analgesia was  
rapid(5-10mins; mean 5.95 mins) and completion of analgesia occured in 
(9-15mins;mean 10.96 mins).  
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Mok et al., in 1986 did a study to evaluate the analgesic efficacy 
and safety of epidural butorphanol 4mg in comparison to that of epidural 
morphine 5mg in patients with postoperative pain. Onset of pain relief with 
epidural butorphanol appeared at 15 minutes and peaked at 30 minutes. 
Maurice Lippmann in 1988 has reported in his study that epidural 
butorphanol 4mg used for postoperative analgesia in non- obstetric 
abdominal surgeries has produced analgesia within 15 minutes. 
Abboud et al. in 1986 studied the efficacy of epidural butorphanol 
for post operative pain relief and reported the onset of analgesia with 1mg 
butorphanol was 15mins. 
Cousins and Mather et al. in 1984  reported the time of onset of 
analgesia with epidural fentanyl 100µg to be 5-10mins. 
Rutter DV et al., in 1981 reported that 100µg of epidural fentanyl 
for postoperative pain relief had a rapid onset of action i.e almost 50% 
reduction in mean pain within 5 minutes. 
In a study by Lomessay A et al., in 1984 concluded that epidural 
fentanyl 200µg provides rapid analgesia that remains optimum during 2 
hours despite the intensity and pain stimulation. 
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Naulty JS et al., in 1985 used different doses of epidural fentanyl in 
parturients following caesarean delivery. They concluded that fentanyl 
100µg produced pain scores of 0 in 3-6 minutes. 
 
QUALITY OF ANALGESIA: 
In our study majority of the patients in both group BB and group BF 
reported good quality of analgesia. None of the patients in both the groups 
required top up dose of local anaesthetics intra operatively. 
Quisqueya T et al., in 1991 compared epidural butorphanol in doses 
of 1mg, 2mg and 4mg with morphine 5mg. He concluded that each dose of 
butorphanol produced greater pain relief than morphine at 15, 30, 45 and 
60 minutes(p <0.05). 
Lytle SA et al., in 1991 did a retrospective analysis with fentanyl 
(50µg) and showed that epidural fentanyl provides good to excellent pain 
relief. 
Sugimoto M et al., in 1997 compared the degree of analgesia using 
different doses of epidural fentanyl and found that epidural fentanyl 25µg 
provided superior analgesia than 12.5µg. 
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Hwang KB, Chung CJ, Lee et al., in 2004 compared analgesic 
efficacy of epidural butorphanol and epidural fentanyl and concluded that 
there was no significant difference in the quality of analgesia between the 
two groups. 
 
POST OPERATIVE PAIN SCORES: 
 In our study the pain scores as assessed on the VAS were low and 
remained low for a significant time in the post operative period in both 
group BB and group BF. The range of post operative pain scores in group 
BB at 1, 2,3,4,5,6,7 hours were between 0-5, where as in BF group for the 
same time interval was between 3-6. There was a statistically significant 
difference in pain score in between both the groups. 
DURATION OF ANALGESIA: 
 In our study the duration of analgesia was significantly prolonged 
with the addition of opioids to local anaesthetics. The mean duration of 
analgesia with the group BF was 5.2 hours, where as in Group BB was 7.1 
hours. Our study was consistent with those observed by Cousins and 
Marther et al.,1984 and Peach et al.,   in 1990, who observed the mean 
duration of analgesia with epidural fentanyl was 5.7 hours and 5.2 hours 
respectively. Malik et al ., in 2006 studied the duration of analgesia with 
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epidural butorphanol with varying doses and observed that epidural 
butorphanol produced a significantly longer duration of analgesia when 
compared to fentanyl. 
 
SIDE EFFECTS: 
 Narcotics are well known for their potential side effects such as 
pruritis, nausea, vomiting, urinary retention and respiratory depression. 
Delayed respiratory depression is one of the most troublesome of these 
side effects. 
Pruritis: In our study 3.33% of patients in butorphanol group had pruritis 
and whereas 16.66% of patients in fentanyl group had pruritis which was 
statistically insignificant (p>0.05). 
In a study by Ackermann et al., in 1989, 7% of patients reported 
pruritis with 2mg of epidural butorphanol and in a study by Palacios et al 
in 1991, 1.4% of patients reported pruritis with 2mg of butorphanol. 
In a study by Lytle SA et al., in 1991 using fentanyl 50µg ,4% of 
patients had pruritis. 
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Nausea and vomiting: 
 In our study 3.3% of patients in butorphanol group had nausea 
whereas in fentanyl group  13.33% of patients had nausea which was  
insignificant statistically (p>0.05). 
No patients on epidural butorphanol had nausea or vomiting in 
separate studies conducted by JS Naulty et al., and Catherine O Hunt           
et al. In a study by Lytle SA et al., in 1991, nausea was reported in 25.5% 
of cases. 
Premila Malik, Chhavi Manchanda, Naveen Malhotra in 2006 
compared the efficacy of epidural butorphanol 2mg and fentanyl 50µg 
found that the incidence of nausea and vomiting was higher in fentanyl 
group. 
Respiratory depression: In our current study, none of the patients 
in butorphanol group or fentanyl group reported respiratory depression 
which was consistent with the following studies. 
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No patients had respiratory depression with butorphanol in studies 
conducted by Maurice Lippmann et al., in 1988, Catherine O Hunt et al 
in 1989, JS Naulty et al., in 1989. 
Rutter DV et al., in 1981 reported decrease in respiratory rate in 
patients who received 100µg of fentanyl. 
Negre I et al., in 1987 observed the effect of 200µg of fentanyl on 
ventilatory response to carbon dioxide and concluded that fentanyl induces 
a non systemic ventilatory response that may be due to rostral spread of the 
drug. 
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SUMMARY 
This prospective randomized controlled clinical comparative study 
entitled “A COMPARATIVE STUDY OF EPIDURAL 
BUTORPHANOL  AND  EPIDURAL  FENTANYL AS ADJUVANTS  
TO  BUPIVACAINE IN LOWER ABDOMINAL SURGERIES ” was 
conducted in 60 patients of either sex, aged between 20- 60 years of ASA 
grade Ι and ΙΙ admitted for elective surgeries to Thanjavur Medical 
College, from  June 2012 to July 2014. 
Written informed consent was taken and pre-anaesthetic 
evaluation was done. All cases were given epidural anaesthesia using 
0.5% bupivacaine with butorphanol 1mg(total volume of 20 ml) or 0.5% 
bupivacaine with fentanyl 100µg(total volume of 20ml) depending on 
study group BB or BF. In the perioperative period the following 
parameters were observed:  
1. Vital parameters- heart rate, Spo2, blood pressure and respiratory 
rate 
2. Onset and completion of analgesia 
3. Quality of analgesia 
4. Duration of analgesia 
5. Sedaton score 
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6. Side effects 
In the postoperative period, intensity of pain was assessed using 
Linear Visual analog scale. 
Demographic profile (age, sex) was comparable in both groups. 
 
INTRA OPERATIVE HEMODYNAMICS: 
 The mean arterial blood pressure in group BB was 83.4 mm Hg ± 
1.26 (S.D)  and in group BF was 81.3mmHg±1.05(S.D). 
The mean pulse rate in Group BB was 75.6±1.35(S.D.)/minutes and 
in Group BF was 74.67±0.92(S.D.)/minutes 
The mean respiratory rate in group BB was 12.6± 1.32(S.D.)/min 
and in group BF was 12.9±0.98(S.D.)/min. The statistical study showed no 
significant difference in the mean arterial blood pressure,mean pulse rate, 
mean  respiratory rate between the 2 groups.  
 Oxygen saturation (SPO2) maintained between 97-98% in both the 
groups. None of the patients in both the groups showed 
desaturation(SPO2<95%). 
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Onset and completion of analgesia:  
In BB group mean onset of analgesia was 5-9mins and completion 
of analgesia occurred earlier(9-14 mins, mean 10.10 mins). In BF group 
also the onset of analgesia was  rapid(5-10mins; mean 5.95 mins) and 
completion of analgesia occured in (9-15mins;mean 10.96 mins). But there 
was no statistically significant difference between the two groups. 
Duration of analgesia: The duration of analgesia was longer in 
butorphanol group which ranged from 5to8 hours with a mean of  7.6 
hours compared to fentanyl group which ranged from 3 to 7 hours with a 
mean of  5.8 hours.This was clinically and statistically significant (p< 
0.001). 
Quality of analgesia:The  quality of analgesia was good in both BB and 
BF group.There was no statistical significance between both the groups. 
Sedation score: 
The mean value of subjective sedation score was 1.00±0.06 in group 
BF and 3.0±0.64 in group BB. This was statistically significant (p< 0.001).  
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Side effects 
The frequency of pruritis, nausea and vomiting was more in fentanyl 
group when compared to butorphanol group but this was not statistically 
significant. Respiratory depression was not reported in both the groups. 
 
  
123 
 
CONCLUSION 
It can be concluded from the above study that epidural butorphanol 
provides a longer duration of  good quality of analgesia with fewer side 
effects like sedation which are statistically significant when compared to 
epidural fentanyl. 
In view of its  safety profile, epidural butorphanol can be routinely 
employed as an adjuvant to bupivacaine in epidural anaesthesia for good 
intraoperative and postoperative analgesia  for various surgical procedures. 
However more studies with different dosages and different techniques 
(epidural bolus and infusion) of both the study drugs should be conducted 
to evaluate the efficiency and to conclude the above facts. 
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PROFORMA 
 
NAME:      WEIGHT: 
AGE/SEX:      DIAGNOSIS: 
IP.NO:      TYPE OF SURGERY: 
DATE:      ASA GRADE: 
GROUP: 
PRE-OPERATIVE EVALUATION: 
PULSE RATE:      AIRWAY: 
BLOOD PRESSURE:      CVS: 
RR:      RS: 
PRE-OPERATIVE INVESTIGATIONS: 
Hb%: 
BT/CT: 
BLOOB SUGAR: 
BLOOB UREA: 
SERUM CREATININE: 
ECG: 
X-RAY CHEST: 
PRE MEDICATION: 
ANAESTHETIC TECHNIQUE: 
DRUG DOSE: 
DURATION OF SURGERY:  
TOP UP DOSE(IF ANY): 
 
PARAMATERS STUDIES: 
1.ONSET OF SENSORY BLOCK:     4.QUALITY OF ANALGESIA 
2.COMPLETION OF SENSORY BLOCK:    5.DURATION OF ANALGESIA: 
3.LEVEL OF SENSORY BLOCK:     6, SIDE EFFECTS. 
 
VITAL PARAMETERS: INTRA OPERATIVE 
TIME 
mins 
0 5 10 15 20 25 30 40 50 60 70 80 90 100 110 120 
HR                 
SBP/DBP                 
MAP                 
SPO2                 
RR                 
SEDATION 
SCORE 
                
SIDE 
EFFECTS 
                
 
 
 
 
 
 
 POST OPERATIVE PERIOD: 
TIME 
(HOURS) 
1st  2nd  3rd 4th  5th  6th  7th 8th 
HEART 
RATE 
        
SBP/DBP         
MAP         
RR         
SPO2         
SEDATION 
SCORE 
        
PAIN 
SCORE 
        
SIDE 
EFFECTS 
        
 
 
 
 
 
DURATION OF ANALGESIA: 
 
 
 
 
 
 
 
  
 
KEY TO MASTER CHART 
 
M MALE 
F FEMALE 
PR PULSE RATE 
MAP MEAN ARTERIAL PRESSURE 
SPO2 OXYGEN SATURATION 
RR RESPIRATORY RATE 
SS SEDATION SCORE 
VAS VISUAL ANALOG SCALE 
GROUP BB BUPIVACAINE-BUTORPHANOL 
GROUP BF BUPIVACAINE- FENTANYL 
SB SENSORY BLOCK 
MB MOTOR BLOCK 
Y YES 
N NO 
MINS MINUTES 
HRS HOURS 
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1 RAMASAMY 40 M 45  GENERAL SURGERY 85
BB 88 85 80 78 76 76 74 70 70 70 72 68 70 72 72 72 90 92 82 73
2 MANI 40 M 50  GENERAL SURGERY 80
BB 85 85 80 77 74 72 72 70 68 64 64 62 66 70 74 74 94 87 77 76
3 MAHALINGAM 45 M 50  GENERAL SURGERY 80
BB 95 84 76 76 72 70 70 68 68 64 64 62 62 66 62 68 99 98 92 90
4 RAJAMANI 40 F 48  GENERAL SURGERY 90
BB 92 88 79 78 72 74 70 70 66 64 62 62 60 60 68 70 102 101 98 95
5 DHARMARAJ 45 M 45  GENERAL SURGERY 90
BB 74 76 72 70 68 68 66 64 64 64 62 62 60 64 70 68 82 80 84 78
6 RAJASEKAR 38 M 36  GENERAL SURGERY 95
BB 102 98 96 90 80 82 85 89 76 72 74 76 88 86 89 86 96 90 91 88
7 KUMARESAN 35 M 38  GENERAL SURGERY 85
BB 84 80 75 72 70 69 70 72 72 74 74 72 76 70 72 78 89 89 87 85
8 SHANKAR 42 M 52  GENERAL SURGERY 80
BB 92 90 90 88 86 84 82 80 80 78 78 76 76 74 72 74 77 75 72 70
9 SIVAM 45 M 55  GENERAL SURGERY 75
BB 98 97 96 94 92 90 88 86 84 82 82 82 80 78 76 74 94 87 86 84
10 BALASUBRAMANIAN 50 M 45  GENERAL SURGERY 80
BB 78 76 76 74 72 70 68 68 66 69 69 69 64 66 64 62 96 102 92 90
11 SIVASANKAR 38 M 48  GENERAL SURGERY 95
BB 86 84 82 80 78 78 76 74 72 70 68 68 68 66 64 62 94 92 90 90
12 GANAPATHY 35 M 43  GENERAL SURGERY 80
BB 84 82 80 78 78 76 72 70 66 68 68 64 64 62 66 64 98 98 98 94
13 PARVATHI 42 M 50  GENERAL SURGERY 85
BB 99 96 94 92 90 88 86 84 82 82 82 84 80 78 76 74 102 100 96 96
14 AROKIARAJ 45 F 52  GENERAL SURGERY 85
BB 104 100 98 95 92 90 89 86 88 86 84 84 82 80 78 76 92 92 88 86
15 VEDHAMOORTHI 40 M 38  GENERAL SURGERY 80
BB 100 98 96 94 92 90 88 86 84 82 82 82 80 78 76 74 90 90 84 82
16 JESUDAS 34 M 35  GENERAL SURGERY 70
BB 78 76 76 78 74 72 70 70 68 68 68 66 64 62 60 66 94 92 88 88
17 MURUGAIYAN 35 M 48  GENERAL SURGERY 75
BB 86 84 82 80 78 76 74 74 74 76 74 78 76 76 72 72 100 102 96 91
18 RANGANATHAN 42 M 55  GENERAL SURGERY 75
BB 98 96 94 92 90 90 88 86 86 84 84 84 82 80 78 76 84 80 76 73
19 RATHINAM 45 M 50  GENERAL SURGERY 85
BB 92 90 88 86 85 88 84 80 78 76 76 74 72 70 72 70 92 90 91 89
20 BABU 48 F 50  GENERAL SURGERY 90
BB 88 84 80 78 78 80 84 86 86 84 84 84 82 80 78 76 88 86 80 78
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21 KUMARVEL 45 M 50  GENERAL SURGERY 95
BB 102 100 99 98 96 92 90 88 86 84 82 82 80 84 88 84 101 96 94 92
22 VELAUDHAM 42 M 57  GENERAL SURGERY 90
BB 112` 99 98 96 96 94 92 90 88 88 86 86 84 86 84 82 89 85 82 80
23 KARNAN 40 M 50  GENERAL SURGERY 90
BB 100 98 96 94 96 96 98 88 86 89 88 88 84 86 84 86 98 98 96 92
24 PAULRAJ 36 M 49  GENERAL SURGERY 85
BB 98 96 94 92 90 90 92 90 88 88 88 90 88 86 84 82 96 94 90 90
25 PETER SELVAM 38 M 49  GENERAL SURGERY 85
BB 90 88 86 86 84 84 82 80 80 78 76 76 74 72 70 70 98 98 96 94
26 SENAPATHY 46 M 48  GENERAL SURGERY 80
BB 74 72 70 68 66 66 64 62 60 60 62 62 62 64 64 62 94 94 90 90
27 GANDHIMADHY 48 M 50  GENERAL SURGERY 85
BB 72 70 69 68 68 66 66 64 64 62 62 60 62 64 60 60 93 88 86 84
28 PETHAN 45 M 55  GENERAL SURGERY 85
BB 78 76 76 70 68 68 66 66 64 67 67 68 62 62 60 62 90 88 88 84
29 VEERAPANDI 40 M 55  GENERAL SURGERY 90
BB 76 74 72 70 70 68 68 66 66 64 64 64 62 62 60 64 86 82 80 76
30 THIYAGARAJAN 45 M 50 GENERAL SURGERY 90
BB 98 98 96 94 94 92 92 90 88 86 84 84 82 80 80 78 85 80 78 78
31 KRISHNAMOORTHY 45 M 50 GENERAL SURGERY 80
BF 88 86 86 84 84 84 82 82 80 80 80 78 77 76 78 80 94 94 90 90
32 RAJANGAM 48 M 55 GENERAL SURGERY 85
BF 90 90 88 86 85 83 85 84 88 88 86 86 84 84 88 86 93 88 86 84
33 MARIMUTHU 36 M 46 GENERAL SURGERY 90
BF 94 92 92 90 88 86 86 84 88 90 88 88 86 86 88 90 90 88 88 84
34 SAIVARAJ 40 M 45 GENERAL SURGERY 90
BF 90 88 88 86 86 86 84 82 84 86 86 88 86 86 82 84 86 82 80 76
35 PANEERSELVAM 48 M 50 GENERAL SURGERY 85
BF 88 86 84 80 84 84 86 84 82 82 82 82 80 80 82 82 85 80 78 78
36 KENNADY 36 M 48 GENERAL SURGERY 90
BF 100 102 98 96 96 98 94 92 90 88 88 86 88 88 90 92 94 92 88 88
37 MAHALINGAM 38 M 45 GENERAL SURGERY 85
BF 106 102 100 100 96 94 92 88 86 88 88 88 90 90 92 90 100 102 96 91
38 KALAVATHY 42 F 45 GENERAL SURGERY 75
BF 90 88 89 86 88 89 88 88 86 86 84 84 84 82 82 84 84 80 76 73
39 SIVASANKAR 35 M 50 GENERAL SURGERY 75
BF 88 88 86 86 86 84 84 86 86 84 84 84 82 80 80 82 92 90 91 89
40 PERUMANANDHAM 32 M 55 GENERAL SURGERY 80
BF 72 72 70 70 68 66 64 62 66 66 66 66 64 62 62 64 88 86 80 78
41 GOVINDARAJ 40 M 49 GENERAL SURGERY 80
BF 78 78 76 74 72 70 70 70 68 66 64 64 66 66 64 68 101 96 94 92
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42 MADHIALAGAN 44 M 50 GENERAL SURGERY 85
BF 88 88 86 86 86 84 84 82 80 80 80 80 82 82 80 80 89 85 82 80
43 PERUMAL 49 M 50 GENERAL SURGERY 90
BF 100 98 96 96 94 92 92 88 90 90 90 92 92 90 90 90 98 98 96 92
44 JOHN 35 M 56 GENERAL SURGERY 95
BF 98 98 96 96 94 92 90 88 90 90 90 89 88 90 90 94 96 94 90 90
45 KATHIRAVAN 32 M 48 GENERAL SURGERY 60
BF 80 78 75 76 82 88 80 78 78 80 80 80 82 80 80 80 98 98 96 94
46 LEELAVATHY 46 F 45 GYNAECOLOGICAL 80
BF 88 86 84 82 80 86 88 84 82 80 80 80 78 78 77 80 90 92 82 73
47 VELMURUGAN 48 M 45 GENERAL SURGERY 85
BF 90 89 88 84 84 82 80 78 76 80 80 80 84 82 84 82 94 87 77 76
48 PANDIYAN 30 M 46 GENERAL SURGERY 90
BF 88 88 86 84 84 82 80 80 78 76 76 76 74 72 72 70 99 98 92 90
49 MOORTHY 39 M 45 GENERAL SURGERY 90
BF 100 89 98 96 94 94 94 92 90 90 90 90 88 88 86 86 102 101 98 95
50 MURUGESAN 44 M 42 GENERAL SURGERY 90
BF 88 88 86 84 82 82 80 80 78 78 78 78 76 74 78 80 82 80 84 78
51 RAJAMANI 49 M 38 GYNAECOLOGICAL 95
BF 114 112 98 94 90 90 88 90 88 88 86 86 84 86 84 82 90 88 86 86
52 PETHAIYAN 40 M 40 GENERAL SURGERY 90
BF 100 98 96 94 92 92 90 88 86 86 86 86 84 82 86 86 78 78 74 72
53 THANGARAJ 45 M 45 GENERAL SURGERY 85
BF 78 76 72 70 68 70 70 72 72 70 72 72 72 70 72 70 96 90 91 88
54 VEERAMANI 50 M 42 GENERAL SURGERY 80
BF 76 76 74 78 78 76 76 74 72 72 72 70 70 72 72 72 89 89 87 85
55 KANNAIYAN 52 M 55 GENERAL SURGERY 75
BF 88 86 84 84 82 82 80 80 78 76 76 76 74 76 78 72 77 75 72 70
56 THENARASU 35 M 50 GENERAL SURGERY 85
BF 98 96 94 92 90 88 86 86 86 88 84 84 82 80 82 82 94 87 86 84
57 KARUNANIDHI 35 M 50 GENERAL SURGERY 90
BF 76 74 72 68 66 64 64 68 66 68 70 70 70 72 72 70 96 102 92 90
58 CHELLIAYA 46 M 48 GENERAL SURGERY 90
BF 80 82 85 78 76 74 72 70 72 72 72 70 70 74 72 70 94 92 90 90
59 THILAGARESAN 42 M 52 GENERAL SURGERY 75
BF 78 74 72 72 70 70 72 72 70 70 68 66 68 70 70 108 106 100 100
60 ANANDHAN 40 M 50 GENERAL SURGERY 90
BF 88 86 86 84 82 82 80 80 82 82 80 80 82 84 80 104 102 100 96
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1 RAMASAMY
2 MANI
3 MAHALINGAM
4 RAJAMANI
5 DHARMARAJ
6 RAJASEKAR
7 KUMARESAN
8 SHANKAR
9 SIVAM
10 BALASUBRAMANIAN
11 SIVASANKAR
12 GANAPATHY
13 PARVATHI
14 AROKIARAJ
15 VEDHAMOORTHI
16 JESUDAS
17 MURUGAIYAN
18 RANGANATHAN
19 RATHINAM
20 BABU
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10 4 T6 GOOD 7
10 4 T6 GOOD 7
12 4.5 T6 GOOD 7.5
10 4.5 T6 GOOD 5.5
9 4.5 T8 GOOD 7
12 4.5 T6 GOOD 5.5
8 4.5 T6 GOOD 6.5
10 4.5 T6 GOOD 6.5
10 4 T6 FAIR 7.5
12 4 T6 GOOD 7.5
10 4 T8 GOOD 7.5
8 4 T6 GOOD 7.5
10 4.5 T6 GOOD 5
10 4.5 T6 GOOD 7
8 4.5 T6 GOOD 7.5
10 4.5 T8 GOOD 7
9 4.5 T6 GOOD 7.5
12 4.5 T6 GOOD 7
10 5 T6 GOOD 7
12 5 T6 GOOD 7
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21 KUMARVEL
22 VELAUDHAM
23 KARNAN
24 PAULRAJ
25 PETER SELVAM
26 SENAPATHY
27 GANDHIMADHY
28 PETHAN
29 VEERAPANDI
30 THIYAGARAJAN
31 KRISHNAMOORTHY
32 RAJANGAM
33 MARIMUTHU
34 SAIVARAJ
35 PANEERSELVAM
36 KENNADY
37 MAHALINGAM
38 KALAVATHY
39 SIVASANKAR
40 PERUMANANDHAM
41 GOVINDARAJ
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9 4 T8 GOOD 7
10 4.5 T6 GOOD 7
10 4.5 T6 GOOD 7
12 5 T6 GOOD 6.5
10 4.5 T8 GOOD 6.5
8 4.5 T8 GOOD 10
12 4.5 T6 GOOD 10
10 5 T6 GOOD 7.5
10 4.5 T6 GOOD 7.5
10 4.5 T6 GOOD 7.5
10 5.5 T6                   GOOD 5
10 5.5 T6 GOOD 5
12 5.5 T6 GOOD 3.5
10 6 T6 GOOD 5
10 6 T6 GOOD 5
10 6 T6 GOOD 5
12 6 T6 FAIR 5.5
10 5.5 T6 GOOD 5
12 5.5 T6 GOOD 5.5
10 5 T6 GOOD 8
10 5 T8 GOOD 8
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42 MADHIALAGAN
43 PERUMAL
44 JOHN
45 KATHIRAVAN
46 LEELAVATHY
47 VELMURUGAN
48 PANDIYAN
49 MOORTHY
50 MURUGESAN
51 RAJAMANI
52 PETHAIYAN
53 THANGARAJ
54 VEERAMANI
55 KANNAIYAN
56 THENARASU
57 KARUNANIDHI
58 CHELLIAYA
59 THILAGARESAN
60 ANANDHAN
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12 5 T6 GOOD 5
10 5 T6 GOOD 5.5
10 5.5 T6 GOOD 5.5
10 5.5 T6 GOOD 5
10 5.5 T6 FAIR 5
10 5.5 T6 GOOD 5
10 5.5 T6 GOOD 8
12 5.5 T6 GOOD 5
10 5.5 T8 GOOD 5
10 5.5 T6 GOOD 5
12 5.5 T6 GOOD 5
12 6 T6 GOOD 5.5
10 5.5 T6 GOOD 5
10 5.5 T6 FAIR 5
10 5.5 T6 GOOD 4.5
10 5.5 T6 GOOD 3.5
10 5 T6 GOOD 3.5
12 5 T6 GOOD 5
10 5.5 T6 GOOD 5.5
